Document:

Document

Exhibit 10.1

EXECUTION COPY
$1,050,000,000

MPH ACQUISITION HOLDINGS LLC

5.50% Senior Secured Notes due 2028

Purchase Agreement
August 17, 2021
Goldman Sachs & Co. LLC, 

as Representative of the Initial Purchasers

c/o Goldman Sachs & Co. LLC 
200 West Street 
New York, NY 10282

Ladies and Gentlemen:

MPH Acquisition Holdings LLC, a Delaware limited liability company (the “Issuer”), proposes to issue and sell to the several initial purchasers listed in Schedule 1 hereto (the “Initial Purchasers”), for whom you are acting as representative (the “Representative”), $1,050,000,000 principal amount of 5.50% Senior Secured Notes due 2028 (the “Securities”).  The Securities will be issued pursuant to an indenture (the “Indenture”), to be dated as of the Closing Date (as defined below), by and among the Issuer, the Guarantors (as defined below) and Wilmington Trust, National Association, as trustee (in such capacity, the “Trustee”) and as collateral agent (in such capacity, the “Notes Collateral Agent”).
The Securities will be sold to the Initial Purchasers without being registered under the Securities Act of 1933, as amended (the “Securities Act”), in reliance upon an exemption therefrom.  The Issuer has prepared a preliminary offering circular dated August 16, 2021 (together with documents incorporated or deemed to be incorporated by reference therein, the “Preliminary Offering Circular”) and will prepare an offering circular dated the date hereof (together with documents incorporated or deemed to be incorporated by reference therein, the “Offering Circular”) setting forth or incorporating by reference information concerning the Issuer, the Guarantors and the Securities.  Copies of the Preliminary Offering Circular have been, and copies of the Offering Circular will be, delivered by the Issuer to the Initial Purchasers pursuant to the terms of this purchase agreement (this “Agreement”).  The Issuer hereby confirms that it has authorized the use of the Preliminary Offering Circular, the Time of Sale Information (as defined below) and the Offering Circular in connection with the offering and resale of the Securities by the Initial Purchasers in the manner contemplated by this Agreement.  The terms “supplement”, “amendment” and “amend” as used herein with respect to the Preliminary Offering Circular, the Time of Sale Information and the Offering Circular shall include all documents subsequently filed by MultiPlan Corporation with the Securities and Exchange Commission (the “Commission”) pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are deemed to be incorporated by reference therein. Capitalized terms used but not defined herein shall have the meanings given to such terms in the Preliminary Offering Circular.
The Securities will be guaranteed (the “Guarantees”), jointly and severally, on a senior secured basis, (i) by each of the Issuer’s subsidiaries that guarantee the Issuer’s New Credit Facility (as defined below) as described in the Time of Sale Information, with such subsidiaries listed on Schedule 2 hereto (the “Guarantors”), and (ii) any other subsidiary of the Issuer formed or acquired following the date hereof that is required to provide an additional guarantee in accordance with the terms of the Indenture, and their respective successors and assigns, pursuant to their respective guarantee.

    

The Securities and the Guarantees will be secured on a first-lien pari passu basis with the obligations under the New Credit Facility, subject to Permitted Liens (as defined below) and certain exceptions as described in the Time of Sale Information and the Offering Circular under the caption “Description of Notes”, by liens on the assets of the Issuer and the Guarantors that have also been pledged on a first-priority basis as collateral securing the Issuer’s New Credit Facility as described in the Time of Sale Information and the Offering Circular (other than the Excluded Assets (as defined in the Indenture)) (the “Collateral”). The liens on the Collateral securing the Securities will be created by, and certain rights of the holders of the Securities with respect to the Collateral will be documented by, a security agreement dated as of the Closing Date, to be entered into by and among the Issuer and the Guarantors, together with other agreements and instruments evidencing or creating a security interest, in each case, in favor of the Notes Collateral Agent, for the benefit of the Trustee and the holders of the Securities (collectively, the “Security Agreements”). The liens on the Collateral securing the Securities and the rights of the holders of the Securities with respect to the Collateral will be subject to an intercreditor agreement, dated as of the Closing Date (the “Intercreditor Agreement”), by and among the Trustee, the Notes Collateral Agent and the New Credit Facility Agent (as defined below), and acknowledged by the Issuer and the Guarantors.
The Issuer intends to use (i) the net proceeds from the sale of the Securities and (ii) the borrowings received in connection with entering into that certain New First Lien Credit Agreement (the “New Credit Agreement”)], dated as of the date hereof, by and among the Issuer, the lenders party thereto and Goldman Sachs Lending Partners LLC, in its capacity as administrative and collateral agent thereunder (the “New Credit Facility Agent”) (the “New Credit Facility”) to (x) repay all of the Issuer’s outstanding indebtedness under that certain Credit Agreement, dated as of June 7, 2016, by and among MPH Acquisition Corp 1, a Delaware corporation, the Issuer, the co-obligors party thereto from time to time, the lenders and letter of credit issuers party thereto from time to time, and Barclays Bank PLC, in its capacities as administrative agent, collateral agent, swingline lender and letter of credit issuer and each of the other entities from time to time (as amended, restated, supplemented or otherwise modified from time to time, the “Existing Credit Facility”) and (y) to pay the related fees and expenses in connection with the transactions contemplated in the above clauses (i) and (ii) therewith, as described under the caption “Use of Proceeds” in the Time of Sale Information and the Offering Circular (such transactions, collectively, the “Refinancing”).
At or prior to the time when sales of the Securities were first made (the “Time of Sale”), the following information shall have been prepared (collectively, the “Time of Sale Information”):  the Preliminary Offering Circular, as supplemented and amended by the written communications listed on Schedule 3 hereto and any documents subsequently filed by MultiPlan Corporation with the Commission that are deemed to be incorporated by reference therein.
The Issuer and the Guarantors hereby confirm their agreement with the several Initial Purchasers concerning the purchase and resale of the Securities, as follows:
1.     Purchase and Resale of the Securities.
(a)The Issuer agrees to issue and sell the Securities to the several Initial Purchasers as provided in this Agreement, and each Initial Purchaser, on the basis of the representations, warranties and agreements set forth herein and subject to the conditions set forth herein, agrees, severally and not jointly, to purchase from the Issuer the respective principal amount of Securities set forth opposite such Initial Purchaser’s name in Schedule 1 hereto at a price equal to 98.75% of the principal amount thereof plus accrued interest, if any, from August 24, 2021 to the Closing Date. The Issuer will not be obligated to deliver any of the Securities except upon payment for all the Securities to be purchased as provided herein. 
(b)The Issuer understands that the Initial Purchasers intend to offer the Securities for resale on the terms set forth in the Time of Sale Information.  Each Initial Purchaser, severally and not jointly, represents, warrants and agrees that:
(i).it is a qualified institutional buyer within the meaning of Rule 144A under the Securities Act (a “QIB”) and an accredited investor within the meaning of Rule 501(a) of Regulation D under the Securities Act (“Regulation D”);
-2-

(ii).it has not solicited offers for, or offered or sold, and will not solicit offers for, or offer or sell, the Securities by means of any form of general solicitation or general advertising within the meaning of Rule 502(c) of Regulation D or in any manner involving a public offering within the meaning of Section 4(a)(2) of the Securities Act; and
(iii).it has not solicited offers for, or offered or sold, and will not solicit offers for, or offer or sell, the Securities as part of their initial offering except:
(A)    within the United States to persons whom it reasonably believes to be QIBs in transactions pursuant to Rule 144A under the Securities Act (“Rule 144A”) and in connection with each such sale, it has taken or will take reasonable steps to ensure that the purchaser of the Securities is aware that such sale is being made in reliance on Rule 144A; or
(B)    in accordance with the restrictions set forth in Exhibit B hereto.
(c)Each Initial Purchaser acknowledges and agrees that the Issuer and, for purposes of the “no registration” opinions to be delivered to the Initial Purchasers pursuant to Sections 6(f) and 6(g), counsel for the Issuer and counsel for the Initial Purchasers, respectively, may rely upon the accuracy of the representations and warranties of the Initial Purchasers, and compliance by the Initial Purchasers with their agreements, contained in paragraph (b) above (including Exhibit B hereto), and each Initial Purchaser hereby consents to such reliance.
(d)The Issuer acknowledges and agrees that the Initial Purchasers may offer and sell the Securities to or through any affiliate of an Initial Purchaser and that any such affiliate may offer and sell the Securities purchased by it to or through any Initial Purchaser.
(e)The Issuer and the Guarantors acknowledge and agree that the Initial Purchasers are acting solely in the capacity of an arm’s length contractual counterparty to the Issuer and the Guarantors with respect to the offering of the Securities contemplated hereby (including in connection with determining the terms of the offering) and not as financial advisors or fiduciaries to, or agents of, the Issuer, the Guarantors or any other person.  Additionally, no Initial Purchaser is advising the Issuer, the Guarantors or any other person as to any legal, tax, investment, accounting or regulatory matters in any jurisdiction.  The Issuer and the Guarantors shall consult with their own advisors concerning such matters and shall be responsible for making their own independent investigation and appraisal of the transactions contemplated hereby, and no Initial Purchaser shall have any responsibility or liability to the Issuer or the Guarantors with respect thereto.  Any review by any Initial Purchaser of the Issuer, the Guarantors and the transactions contemplated hereby or other matters relating to such transactions will be performed solely for the benefit of such Initial Purchaser, as the case may be, and shall not be on behalf of the Issuer, the Guarantors or any other person.
2.     Payment and Delivery.
(a)Payment for and delivery of the Securities will be made at the offices of Davis Polk & Wardwell llp, 450 Lexington Avenue, New York, New York 10017, at 10:00 A.M., New York City time, on August 24, 2021, or at such other time or place on the same or such other date, not later than the fifth business day thereafter, as the Initial Purchasers and the Issuer may agree upon in writing.  The time and date of such payment and delivery is referred to herein as the “Closing Date.”
(b)The Securities shall be delivered by the Issuer to the Initial Purchasers (or as the Representative may direct) through the facilities of The Depository Trust Company (“DTC”) against payment by the Initial Purchasers of the amount specified in Section 1(a) by means of wire transfer of immediately available funds to an account previously identified by the Issuer on or prior to the Closing 
-3-

Date.  The Securities shall be evidenced by one or more certificates in global form (collectively, the “Global Note”) registered in such names as the Representative may request upon at least one business day’s notice prior to the Closing Date and having an aggregate principal amount corresponding to the aggregate principal amount of the Securities.  Each Global Note will be made available for inspection by the Initial Purchasers not later than 1:00 P.M., New York City time, on the business day prior to the Closing Date.
3.     Representations and Warranties of the Issuer and the Guarantors.  The Issuer and the Guarantors jointly and severally represent and warrant to each Initial Purchaser that:
(a)Preliminary Offering Circular, Time of Sale Information and Offering Circular.  The Time of Sale Information, at the Time of Sale, did not, and at the Closing Date, will not, and the Offering Circular, in the form first used by the Initial Purchasers to confirm sales of the Securities and as of the Closing Date, will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided that the Issuer and the Guarantors make no representation or warranty with respect to any statements or omissions made in reliance upon and in conformity with information relating to any Initial Purchaser furnished to the Issuer in writing by such Initial Purchaser through the Representative expressly for use in the Preliminary Offering Circular, the Time of Sale Information or the Offering Circular as set forth in Section 7(b) hereof. 
(b)Incorporated Documents. The documents incorporated or deemed to be incorporated by  reference in the Preliminary Offering Memorandum, the Time of Sale Information and the Offering Memorandum, when they were or are filed with the Commission, conformed or will conform in all material respects with the requirements of the Exchange Act and the applicable rules and regulations of the Commission thereunder, and none of such documents contained or will contain any untrue statement of a material fact or omitted or will omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.
(c)Additional Written Communications.  The Issuer and the Guarantors (including their respective affiliates, agents and representatives, other than the Initial Purchasers in their capacity as such) have not prepared, made, used, authorized, approved or referred to, and each of them agrees that it will not prepare, make, use, authorize, approve or refer to any written communication that constitutes an offer to sell or solicitation of an offer to buy the Securities (each such communication by the Issuer and the Guarantors or their agents and representatives (other than a communication referred to in clauses (i), (ii) and (iii) below) an “Issuer Written Communication”) other than (i) the Preliminary Offering Circular, (ii) the Offering Circular, (iii) the documents listed on Schedule 3 hereto, including a pricing supplement substantially in the form of Exhibit A hereto, which constitute part of the Time of Sale Information, and (iv) any electronic road show or other written communications, in each case used in accordance with Section 4(c).  Each such Issuer Written Communication does not conflict with the information contained in the Time of Sale Information or the Offering Circular (that has not been superseded or modified) and, when taken together with the Time of Sale Information at the Time of Sale, did not, and at the Closing Date will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided that the Issuer and the Guarantors make no representation and warranty with respect to any statements or omissions made in any such Issuer Written Communication in reliance upon and in conformity with information relating to any Initial Purchaser furnished to the Issuer in writing by such Initial Purchaser through the Representative expressly for use in any Issuer Written Communication as set forth in Section 7(b) hereof.
(d)Financial Statements.  The consolidated historical financial statements of MultiPlan Corporation and its subsidiaries and the related notes thereto included in each of the Time of Sale Information and the Offering Circular, present fairly in all material respects the consolidated financial position of MultiPlan Corporation and its consolidated subsidiaries as of the dates indicated and the results of their operations and cash flows for the periods specified in conformity with generally accepted 
-4-

accounting principles in the United States (“GAAP”) applied on a consistent basis throughout the periods specified and such financial statements comply in all material respects with the requirements of Regulation S-X of the Commission. 
(e)No Material Adverse Change.  Since June 30, 2021, (i) there has not been any change in the capital stock (other than issuances or repurchases of common stock or grants, forfeitures or vesting of equity-based awards pursuant to earnouts or employee incentive plans or agreements) or long-term debt of the Issuer, the Guarantors or any of their respective subsidiaries, or any dividend or distribution of any kind declared, set aside for payment, paid or made by the Issuer or the Guarantors on any class of capital stock, or any material adverse change, or any development involving a prospective material adverse change, in or affecting the business, properties, rights, assets, management, financial position or results of operations of the Issuer or the Guarantors and their respective subsidiaries taken as a whole; (ii) none of the Issuer, the Guarantors or any of their respective subsidiaries has entered into any transaction or agreement that is material to the Issuer or the Guarantors and their respective subsidiaries taken as a whole or incurred any liability or obligation, direct or contingent, that is material to the Issuer, the Guarantors and their respective subsidiaries taken as a whole; and (iii) none of the Issuer or the Guarantors or any of their respective subsidiaries has sustained any material loss or interference with its business from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor disturbance or dispute or any action, order or decree of any court or arbitrator or governmental or regulatory authority, except in each case as otherwise disclosed in each of the Time of Sale Information and the Offering Circular.
(f)Organization and Good Standing.  The Issuer, the Guarantors and their respective significant subsidiaries (as defined in Rule 1-02 of Regulation S-X) have been duly organized and are validly existing and in good standing under the laws of their respective jurisdictions of organization, are duly qualified to do business and are in good standing in each jurisdiction in which their respective ownership or lease of property or the conduct of their respective businesses requires such qualification, and have all power and authority necessary to own or hold their respective properties and to conduct the businesses in which they are engaged, except where the failure to be so qualified, in good standing or have such power or authority would not, individually or in the aggregate, have a material adverse effect on the business, properties, rights, assets, management, financial position or results of operations of the Issuer, the Guarantors and their respective subsidiaries taken as a whole or on the performance by the Issuer and the Guarantors of their obligations under the Transaction Documents (a “Material Adverse Effect”).  As of the date hereof, the Issuer does not own or control, directly or indirectly, more than fifty percent (50%) of the outstanding equity securities or interests in any corporation, association or other entity other than the subsidiaries listed in Schedule 2 to this Agreement.
(g)Capitalization.  As of June 30, 2021, on an as adjusted basis, after giving effect to the Refinancing, each of MultiPlan Corporation and its subsidiaries (on a consolidated basis) and the Issuer and its subsidiaries (on a consolidated basis) would have had the issued and outstanding capitalization as set forth in each of the Time of Sale Information and the Offering Circular under the heading “Capitalization” (under the “As Adjusted” column, including the footnotes thereto).  All the outstanding shares of capital stock or other equity interests of each subsidiary of the Issuer have been duly and validly authorized and issued, are fully paid and non-assessable and are owned directly or indirectly by the Issuer, free and clear of any lien, charge, encumbrance, security interest, restriction on voting or transfer or any other claim of any third party (collectively, “Liens”), except for restrictions on transfer imposed by applicable securities laws and liens permitted under the Indenture on the Closing Date (as described in the Time of Sale Information and the Offering Circular) (the “Permitted Liens”).
(h)Due Authorization.  The Issuer and the Guarantors have the full right, power and authority to execute and deliver the Transaction Documents (as defined below), and all action required to be taken for the due and proper authorization, execution and delivery of each of the Transaction Documents to which it is party and the consummation of the transactions contemplated thereby has been duly and validly taken.  This Agreement, the Securities, the New Credit Agreement, the Security 
-5-

Agreements, the Intercreditor Agreement and the Indenture (including the Guarantees set forth therein) are collectively referred to herein as the “Transaction Documents.”
(i)The Indenture.  The Indenture has been duly authorized by the Issuer and the Guarantors, and on the Closing Date will be duly executed and delivered by the Issuer and the Guarantors and, assuming due execution and delivery in accordance with its terms by the Trustee, will constitute a valid and legally binding agreement of the Issuer and each of the Guarantors enforceable against the Issuer and each of the Guarantors in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or similar laws affecting the enforcement of creditors’ rights generally or by equitable principles relating to enforceability (collectively, the “Enforceability Exceptions”).
(j)The Securities and the Guarantees.  The Securities have been duly authorized by the Issuer and, when the Securities have been duly executed, authenticated, issued and delivered as provided in the Indenture and paid for as provided herein, the Securities will be duly and validly issued and outstanding and will constitute valid and legally binding obligations of the Issuer enforceable against the Issuer in accordance with their terms, subject to the Enforceability Exceptions, and will be entitled to the benefits of the Indenture; and the Guarantees have been duly authorized by each of the Guarantors and, when the Indenture has been duly executed, authenticated, issued and delivered by the Guarantors in accordance with its terms and upon the due execution, authentication, issuance and delivery of the Securities in accordance with the Indenture and the issuance of the Securities in connection with the sale of the Securities to the Initial Purchasers pursuant to this Agreement, will be valid and legally binding obligations of each of the Guarantors, enforceable against each of the Guarantors in accordance with their terms, subject to the Enforceability Exceptions, and will be entitled to the benefits of the Indenture.
(k)Security Agreements and Intercreditor Agreement.  Each of the Security Agreements and Intercreditor Agreement have been duly authorized and, at the Closing Date, will have been executed and delivered by the Issuer and each of the Guarantors to the extent a party thereto, and, at the Closing Date, when duly executed and delivered in accordance with its terms by each of the other parties thereto, will constitute a valid and binding obligation of the Issuer and each of the Guarantors to the extent a party thereto, enforceable against the Issuer or such Guarantor party thereto in accordance with its terms, except as the enforcement thereof may be limited by the Enforceability Exceptions. 
(l)Collateral.  (i) Upon execution and delivery, the Security Agreements will be effective to grant a legal, valid and enforceable security interest in all of the grantor’s right, title and interest in the Collateral to the extent that a legal, valid and enforceable security interest in such Collateral may be created under any applicable law of the United States of America and any states thereof, including, without limitation, the applicable Uniform Commercial Code; and (ii) the Issuer and the Guarantor and their subsidiaries collectively own, have rights in or have the power and authority to collaterally assign rights in the Collateral, free and clear of any liens other than Permitted Liens.
(m)Purchase Agreement.  This Agreement has been duly authorized, executed and delivered by the Issuer and each Guarantor.
(n)MultiPlan Corporation Operations. MultiPlan Corporation does not own any material assets, carry on any material business or conduct any material operations other than the holding of equity securities of the Issuer and neither Multiplan Corporation nor any holding company through which Multiplan Corporation holds equity securities of the Issuer has any assets or liabilities other than its ownership of the Issuer.
(o)Descriptions of the Transactions.  Each Transaction Document conforms in all material respects to the description thereof contained in each of the Time of Sale Information and the Offering Circular. 
-6-

(p)No Violation or Default.  None of the Issuer or any of the Guarantors is in violation of its charter or by-laws or similar organizational documents.  None of the Issuer, the Guarantors or any of their respective subsidiaries is (i) in default, and no event has occurred that, with notice or lapse of time or both, would constitute such a default, in the due performance or observance of any term, covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Issuer, the Guarantors or any of their respective subsidiaries is a party or by which the Issuer, the Guarantors or any of their respective subsidiaries is bound or to which any property, right or asset of the Issuer, the Guarantors or any of their respective subsidiaries is subject; or (ii) in violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental or regulatory authority, except, in the case of clauses (i) and (ii) above, for any such default or violation that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
(q)No Conflicts.  The execution, delivery and performance by the Issuer and each of the Guarantors of each of the Transaction Documents to which it is a party, the issuance and sale of the Securities (including the Guarantees), the granting and perfection of liens and security interests in the Collateral pursuant to the Security Agreements, and compliance by the Issuer and each of the Guarantors with the terms thereof and the consummation of the transactions contemplated by the Transaction Documents will not (i) conflict with or result in a breach or violation of any of the terms or provisions of, or result in the creation or imposition of any Lien pursuant to, any agreement or other instrument binding upon the Issuer or any Guarantor or to which any of their properties is subject, (ii) result in any violation of the provisions of the charter or by-laws or similar organizational documents of the Issuer or any Guarantor or (iii) result in the violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental or regulatory authority, except, in the case of clauses (i) and (iii) above, for any such conflict, breach, violation, default, lien, charge or encumbrance that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
(r)No Consents Required.  Assuming the accuracy of the representations and warranties of the Initial Purchasers contained in Section 1(b) (including Exhibit B hereto) and their compliance with their agreements set forth therein, no consent, approval, authorization, order, registration or qualification of or with any court or arbitrator or governmental or regulatory authority is required for the execution, delivery and performance by the Issuer and each of the Guarantors of each of the Transaction Documents to which any of them is a party, the issuance and sale of the Securities (including the Guarantees), the grant and perfection of liens and security interests in the Collateral pursuant to the Security Agreements, and compliance by the Issuer and each of the Guarantors with the terms thereof and the consummation of the transactions contemplated by the Transaction Documents, except for (i) such consents, approvals, authorizations, orders and registrations or qualifications as may be required under applicable state securities laws in connection with the purchase and resale of the Securities by the Initial Purchasers or as shall have been obtained or made prior to the Closing Date, and is in full force and effect on the Closing Date, (ii) the filing of UCC-1 financing statements as may be required to perfect or secure the priority of the security interests granted in favor of the Notes Collateral Agent for the benefit of itself, the Trustee and each holder of the Securities pursuant to the Security Agreements, (iii) any filings required with the USPTO and any filings required with the USCO as may be required to perfect or secure the priority of the security interests granted in favor of the Notes Collateral Agent for the benefit of itself, the Trustee and each holder of the Securities pursuant to the Security Agreements and (iv) where the failure to obtain any such consents, approvals, authorizations, orders, registrations or qualifications or make such filings would not impair, in any material respect, the ability of the Issuer and the Guarantors to consummate the transactions contemplated hereby.
(s)Legal Proceedings.  Except as described in each of the Time of Sale Information and the Offering Circular, (i) there are no legal, governmental or regulatory investigations, actions, demands, claims, suits, arbitrations, inquiries or proceedings (“Actions”) pending, to which the Issuer, the 
-7-

Guarantors or any of their respective subsidiaries is or may be a party or to which any property, right or asset of the Issuer, the Guarantors or any of their respective subsidiaries is or may be the subject that, individually or in the aggregate, if determined adversely to the Issuer, the Guarantors or any of their respective subsidiaries, could reasonably be expected to have a Material Adverse Effect; and (ii) no such Actions are threatened or, to the knowledge of the Issuer and each of the Guarantors, contemplated by any governmental or regulatory authority or by others that, individually or in the aggregate, if determined adversely to the Issuer, the Guarantors or any of their respective subsidiaries, could reasonably be expected to have a Material Adverse Effect.
(t)Independent Accountants.  PricewaterhouseCoopers LLP, who has audited certain consolidated financial statements of MultiPlan Corporation and its subsidiaries, are independent public accountants with respect to MultiPlan Corporation and its subsidiaries within the applicable rules and regulations adopted by the Commission and the Public Company Accounting Oversight Board (United States) and as required by the Securities Act.
(u)Real and Personal Property.  None of the Issuer, the Guarantors or their respective subsidiaries owns any material real property. The Issuer, the Guarantors and their respective subsidiaries have valid rights to lease or otherwise use, all items of real and personal property that are material to the respective businesses of the Issuer, the Guarantors and their respective subsidiaries, in each case, free and clear of all liens, encumbrances, claims and defects and imperfections of title except those that (i) do not materially interfere with the use made and proposed to be made of such property by the Issuer, the Guarantors and their respective subsidiaries, (ii) could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect or (iii) secure the indebtedness under the Existing Credit Facility, the New Credit Facility and the Indenture, as well as the other Permitted Liens. 
(v)Intellectual Property.  (i) The Issuer, the Guarantors and their respective subsidiaries own or have the right to use all patents, patent applications, trademarks, service marks, trade names, trademark registrations, service mark registrations, domain names and other source indicators, copyrights and copyrightable works, know-how, trade secrets, systems, procedures, proprietary or confidential information and all other worldwide intellectual property, industrial property and proprietary rights (collectively, “Intellectual Property”) used in the conduct of their respective businesses, except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, and (ii) the Issuer, the Guarantors and their respective subsidiaries have not received any notice of any claim, and to the knowledge of the Issuer and the Guarantors, no such claim has been threatened, relating to Intellectual Property, except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
(w)Investment Company Act.  None of the Issuer or the Guarantors is, and after giving effect to the offering and sale of the Securities and the application of the proceeds thereof as described in each of the Time of Sale Information and the Offering Circular, none of the Issuer or the Guarantors will be, an “investment company” or an entity “controlled” by an “investment company” within the meaning of the Investment Company Act of 1940, as amended, and the rules and regulations of the Commission thereunder (collectively, the “Investment Company Act”).
(x)Taxes.  The Issuer, the Guarantors and their respective subsidiaries have paid all federal, state, local and foreign taxes and filed all tax returns required to be paid or filed through the date hereof (other than with respect to taxes for which appropriate reserves have been made in accordance with GAAP), except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; and except as otherwise disclosed in each of the Time of Sale Information and the Offering Circular, there are no tax deficiencies that have been, or could reasonably be expected to be, asserted against the Issuer, the Guarantors or any of their respective subsidiaries or any of their respective properties or assets that would, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
-8-

(y)Licenses and Permits.  The Issuer, the Guarantors and their respective subsidiaries possess all licenses, sub-licenses, certificates, permits and other authorizations (“Permits”) issued by, and have made all declarations and filings with, the appropriate federal, state, local or foreign governmental or regulatory authorities that are necessary for the ownership or lease of their respective properties or the conduct of their respective businesses as described in each of the Time of Sale Information and the Offering Circular, except where the failure to possess or make the same would not, individually or in the aggregate, have a Material Adverse Effect; and except as described in each of the Time of Sale Information and the Offering Circular, none of the Issuer, the Guarantors or any of their respective subsidiaries has received written notice of any revocation or modification of any such Permit or has any reason to believe that any such Permit will not be renewed in the ordinary course, except where such revocations, modifications or non-renewals would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect.
(z)Compliance with Environmental Laws.  (i) The Issuer, the Guarantors and their respective subsidiaries (x) are, and at all prior times were, in compliance with any and all applicable federal, state, local and foreign laws, rules, regulations, requirements, decisions and orders relating to the protection of human health or safety, the environment, natural resources, hazardous or toxic substances or wastes, pollutants or contaminants (collectively, “Environmental Laws”), (y) have received and are in compliance with all permits, licenses, certificates or other authorizations or approvals required of them under applicable Environmental Laws to conduct their respective businesses, and (z) have not received notice of any actual or potential liability under or relating to any Environmental Laws, including for the investigation or remediation of any disposal or release of hazardous or toxic substances or wastes, pollutants or contaminants, and have no knowledge of any event or condition that would reasonably be expected to result in any such notice, and (ii) there are no costs or liabilities associated with Environmental Laws of or relating to the Issuer, the Guarantors or their respective subsidiaries, except in the case of each of (i) and (ii) above, for any such failure to comply, or failure to receive required permits, licenses or approvals, or cost or liability, as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
(aa)Compliance with Health Care Laws. None of the Issuer, the Guarantors or any of their respective subsidiaries, nor any of their respective officers or directors, has, on behalf of the Issuer, the Guarantors or any of their respective subsidiaries, knowingly or willfully violated any Health Care Laws, except as described in the Time of Sale Information and the Offering Circular or as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. For purposes of this Agreement, “Health Care Laws” shall mean the Civil Monetary Penalties Law (42 U.S.C. § 1320a-7a), the federal Anti-Kickback Statute (42 U.S.C. § 1320a-7b(b )), the civil False Claims Act (31 U.S.C. § 3729 et seq.), the administrative False Claims Law (42 U.S.C. § 1320a-7b(a)), the exclusion laws (42 U.S.C. § 1320a-7), the Health Insurance Portability and Accountability Act of 1996 (Pub. L. No. 104-191) (“HIPAA”), as amended by the Health Information Technology for Economic and Clinical Health Act of 2009 provisions of the American Recovery and Reinvestment Act of 2009 (Division A, Title XIII of Pub. L. No. 111-5) (“HITECH Act”), and comparable state and local laws, and the regulations promulgated pursuant to such statutes, each as amended from time to time.
(ab) Compliance with HIPAA and HITECH. To the extent that the Issuer, the Guarantors or any of their subsidiaries is a “covered entity” or “business associate” as defined under the Administrative Simplification provisions of HIPAA, as amended by the HITECH Act, and all regulations and guidance  promulgated thereunder, the Issuer and its subsidiaries (i) have undertaken all necessary risk analyses and assessments, as required by HIPAA; (ii) have developed and implemented a detailed compliance plan for being in compliance with HIPAA; and (iii) conduct all standard electronic transactions in accordance with HIPAA, except, with respect to clauses (i)-(iii) above, as would not reasonably be expected to have a Material Adverse Effect. To the knowledge of the Issuer and the Guarantors, none of the Issuer, the Guarantors or any of their respective subsidiaries is the subject of any civil or criminal penalty, process, claim, action or proceeding, or any 
-9-

administrative or other regulatory review, survey, process or proceeding (other than routine surveys or reviews conducted by any government health plan or other accreditation entity) that could result in any of the foregoing or that would reasonably be expected to have a Material Adverse Effect, in connection with any actual or potential HIPAA violation by the Issuer or subsidiary.
(ac)Compliance with ERISA.  (i) Each employee benefit plan, within the meaning of Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), for which the Issuer, the Guarantors or any member of their respective “Controlled Groups” (defined as any organization which is a member of a controlled group of corporations within the meaning of Section 414 of the Internal Revenue Code of 1986, as amended (the “Code”)) would have any liability (each, a “Plan”) has been maintained in compliance with its terms and the requirements of any applicable statutes, orders, rules and regulations, including but not limited to ERISA and the Code; (ii) no prohibited transaction, within the meaning of Section 406 of ERISA or Section 4975 of the Code, has occurred with respect to any Plan excluding transactions effected pursuant to a statutory or administrative exemption; (iii) for each Plan that is subject to the funding rules of Section 412 of the Code or Section 302 of ERISA, no Plan has failed (whether or not waived), or is reasonably expected to fail, to satisfy the minimum funding standards (within the meaning of Section 302 of ERISA or Section 412 of the Code) applicable to such Plan; (iv) no Plan is, or is reasonably expected to be, in “at risk status” (within the meaning of Section 430 of the Code or Section 303(i) of ERISA) or “endangered status” or “critical status” (within the meaning of Section 430 of the Code or Section 305 of ERISA); (v) no “reportable event” (within the meaning of Section 4043(c) of ERISA) has occurred or is reasonably expected to occur; (vi) each Plan that is intended to be qualified under Section 401(a) of the Code is so qualified and nothing has occurred, whether by action or by failure to act, which would cause the loss of such qualification; and (vii) none of the Issuer, the Guarantors or any member of their respective Controlled Groups has incurred, nor reasonably expects to incur, any liability under Title IV of ERISA (other than contributions to the Plan or premiums to the PBGC, in the ordinary course and without default) in respect of a Plan (including a “multiemployer plan,” within the meaning of Section 4001(a)(3) of ERISA), except in each case, with respect to the events or conditions set forth in (i) through (vii) hereof, as would not, individually or in the aggregate, have a Material Adverse Effect.
(ad) Compliance with Labor Laws.  Except as would not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect, (i) there is (A) no unfair labor practice complaint pending or, to the knowledge of the Issuer and each of the Guarantors, threatened against the Issuer, any of the Guarantors or any subsidiary of the Issuer or the Guarantors before the National Labor Relations Board, and no grievance or arbitration proceeding arising out of or under collective bargaining agreements pending, or to the knowledge of the Issuer and each of the Guarantors, threatened, against the Issuer, any of the Guarantors or any subsidiary of the Issuer or the Guarantors, (B) no strike, labor dispute, slowdown or stoppage pending or, to the knowledge of the Issuer and each of the Guarantors, threatened against the Issuer, any of the Guarantors or any subsidiary of the Issuer or the Guarantors and (C) no union representation dispute currently existing concerning the employees of the Issuer, the Guarantors or any subsidiary of the Issuer or the Guarantors and, to the knowledge of the Issuer and each of the Guarantors, no union organizing activities taking place and (ii) there has been no violation of any federal, state or local law relating to discrimination in hiring, promotion or pay of employees or of any applicable wage or hour laws.
(ae)Accounting Controls.  MultiPlan Corporation and its subsidiaries maintain systems of “internal control over financial reporting” (as defined in Rule 13a-15(f) of the Exchange Act) that comply with the requirements of the Exchange Act and have been designed by, or under the supervision of, its principal executive and principal financial officers, or persons performing similar functions, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP. MultiPlan Corporation and its subsidiaries maintain internal accounting controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance with management’s general or 
-10-

specific authorizations; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability; (iii) access to assets is permitted only in accordance with management’s general or specific authorization. Except as disclosed in the Time of Sale Information and the Offering Circular, MultiPlan Corporation and its subsidiaries are not aware of any material weaknesses in their internal controls.
(af)Insurance.  The Issuer, the Guarantors and their respective subsidiaries have insurance covering their respective properties, operations, personnel and businesses, including business interruption and “errors and omissions” insurance, which insurance is in amounts and insures against such losses and risks as are generally prudent and customary in the businesses in which they are engaged; and none of the Issuer, the Guarantors or any of their respective subsidiaries has (i) received notice from any insurer or agent of such insurer that capital improvements or other expenditures are required or necessary to be made in order to continue such insurance or (ii) any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage at reasonable cost from similar insurers as may be necessary to continue its business.
(ag)No Unlawful Payments.  None of the Issuer, the Guarantors or any of their respective subsidiaries or, to the knowledge of the Issuer and the Guarantors, any director, officer, agent, employee, controlled affiliate or other person associated with or acting on behalf of the Issuer, the Guarantors or any of their respective subsidiaries has (i) used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expense relating to political activity; (ii) made any direct or indirect unlawful payment to any foreign or domestic government official or employee from corporate funds; (iii) violated or is in violation of any applicable provision of the Foreign Corrupt Practices Act of 1977 (the “FCPA”) or the Bribery Act 2010 of the United Kingdom; or (iv) made any bribe, rebate, payoff, influence payment, kickback or other unlawful payment.  The Issuer and its subsidiaries and, to the knowledge of the Issuer and the Guarantors, their respective controlled affiliates, have instituted and maintain policies and procedures designed to ensure, and which are reasonably expected to continue to ensure, continued compliance with the FCPA.
(ah) Compliance with Money Laundering Laws.  The operations of the Issuer, the Guarantors and their respective subsidiaries are and have been conducted at all times in compliance with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the applicable money laundering statutes of all jurisdictions where the Issuer, the Guarantors and their respective subsidiaries conduct business, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the “Money Laundering Laws”) and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Issuer, the Guarantors, or any of their respective subsidiaries with respect to the Money Laundering Laws is pending or, to the knowledge of the Issuer or any of the Guarantors, threatened. 
(ai)Compliance with Sanctions Laws.  None of the Issuer, the Guarantors, any of their respective subsidiaries or, to the knowledge of the Issuer, the Guarantors, any director, officer, agent, employee or controlled affiliate of the Issuer, the Guarantors or any of their respective subsidiaries is an individual or entity (“Person”) that is, or that is owned or controlled by a Person that is, currently the subject of any sanctions administered or enforced by the Office of Foreign Assets Control of the U.S. Department of the Treasury, the United Nations Security Council, the European Union, Her Majesty’s Treasury, or other relevant sanctions authority (collectively, “Sanctions”), nor is the Issuer, any of the Guarantors or any of their respective subsidiaries located, organized or resident in a country or territory that is the subject of Sanctions.  The Issuer will not directly or indirectly use the proceeds of the offering of the Securities hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other Person, (i) to fund the activities of any Person that, at the time of such funding, is the subject of any Sanctions, (ii) to fund 
-11-

the activities of any Person in Crimea, Cuba, Iran, North Korea, Syria or in any other country or territory, that, at the time of such funding, is the subject of Sanctions, in each case, if such funding would result in a violation by any Person (including any Person participating in the offering, whether as an underwriter, advisor, investor or otherwise) of Sanctions or (iii) in any other manner that will result in a violation by any Person (including any Person participating in the offering, whether as underwriter, advisor, investor or otherwise) of Sanctions.  For the past five years, the Issuer and its subsidiaries have not knowingly engaged in, are not now knowingly engaged in, and will not engage in, any dealings or transactions with any Person, or in any country or territory, that at the time of the dealing or transaction is or was the subject of Sanctions.
(aj)Solvency.  On the Closing Date, after giving effect to the consummation of this offering and the Refinancing, MultiPlan Corporation and its subsidiaries on a consolidated basis will be Solvent.  As used in this paragraph, the term “Solvent” means, with respect to MultiPlan Corporation and its subsidiaries on a consolidated basis (i) the present fair market value (or present fair saleable value) of the assets of MultiPlan Corporation and its subsidiaries are not less than the total amount required to pay the liabilities of MultiPlan Corporation and its subsidiaries on their total existing debts and liabilities (including contingent liabilities) as they become absolute and matured; (ii) MultiPlan Corporation and its subsidiaries are able to realize upon their assets and pay their debts and other liabilities, contingent obligations and commitments as they mature and become due in the normal course of business; (iii) MultiPlan Corporation and its subsidiaries are not incurring debts or liabilities beyond their ability to pay as such debts and liabilities mature; and (iv) MultiPlan Corporation and its subsidiaries are not engaged in any business or transaction, and do not propose to engage in any business or transaction, for which their property would constitute unreasonably small capital after giving due consideration to the prevailing practice in the industry in which MultiPlan Corporation and its subsidiaries are engaged.
(ak) No Restrictions on Subsidiaries.  No subsidiary of the Issuer is prohibited, directly or indirectly, under any agreement or other instrument to which it is a party or is or will be subject, from paying any dividends to the Issuer, from making any other distribution on such subsidiary’s capital stock or similar ownership interest, from repaying to the Issuer any loans or advances to such subsidiary from the Issuer or from transferring any of such subsidiary’s properties or assets to the Issuer or any other subsidiary of the Issuer, except for any such restrictions that are permitted by the Indenture.
(al)No Broker’s Fees.  None of the Issuer, the Guarantors or any of their respective subsidiaries is a party to any contract, agreement or understanding with any person (other than this Agreement) that would give rise to a valid claim against any of them or any Initial Purchaser for a brokerage commission, finder’s fee or like payment in connection with the offering and sale of the Securities.
(am)  Rule 144A Eligibility.  On the Closing Date, the Securities will not be of the same class as securities listed on a national securities exchange registered under Section 6 of the Exchange Act or quoted in an automated inter-dealer quotation system; and each of the Preliminary Offering Circular and the Offering Circular, as of its respective date, contains or will contain all the information that, if requested by a prospective purchaser of the Securities, would be required to be provided to such prospective purchaser pursuant to Rule 144A(d)(4) under the Securities Act.
(an) No Integration.  None of the Issuer, the Guarantors or any of their respective controlled affiliates (as defined in Rule 501(b) of Regulation D) has, directly or through any agent, sold, offered for sale, solicited offers to buy or otherwise negotiated in respect of, any security (as defined in the Securities Act), that is or will be integrated with the sale of the Securities in a manner that would require registration of the Securities under the Securities Act.
-12-

(ao) No General Solicitation or Directed Selling Efforts.  None of the Issuer, the Guarantors or any of their respective controlled affiliates or any other person acting on its or their behalf (other than the Initial Purchasers, as to which no representation is made) has (i) solicited offers for, or offered or sold, the Securities by means of any form of general solicitation or general advertising within the meaning of Rule 502(c) of Regulation D or in any manner involving a public offering within the meaning of Section 4(a)(2) of the Securities Act or (ii) engaged in any directed selling efforts within the meaning of Regulation S under the Securities Act (“Regulation S”), and all such persons have complied with the offering restrictions requirement of Regulation S.
(ap)  Securities Law Exemptions.  Assuming the accuracy of the representations and warranties of the Initial Purchasers contained in Section 1(b) (including Exhibit B hereto) and their compliance with their agreements set forth therein, it is not necessary, in connection with the issuance and sale of the Securities to the Initial Purchasers and the offer, resale and delivery of the Securities by the Initial Purchasers in the manner contemplated by this Agreement, the Time of Sale Information and the Offering Circular, to register the Securities under the Securities Act or to qualify the Indenture under the Trust Indenture Act.
(aq)  No Stabilization.  None of the Issuer or the Guarantors has taken, directly or indirectly, any action designed to or that could reasonably be expected to cause or result in any stabilization or manipulation of the price of the Securities.
(ar)Margin Rules.  Neither the issuance, sale and delivery of the Securities nor the application of the proceeds thereof by the Issuer as described in each of the Time of Sale Information and the Offering Circular will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
(as) Forward-Looking Statements.  No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act) included in any of the Time of Sale Information or the Offering Circular has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith.
(at)Statistical and Market Data.  Nothing has come to the attention of the Issuer or any Guarantor that has caused the Issuer or any Guarantor to believe that the statistical and market-related data included in each of the Time of Sale Information and the Offering Circular is not based on or derived from sources that are reliable and accurate in all material respects.
(au) Disclosure Controls. MultiPlan Corporation and its subsidiaries maintain an effective system of “disclosure controls and procedures” (as defined in Rule 13a-15(e) of the Exchange Act) that is designed to ensure that information required to be disclosed by MultiPlan Corporation in reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to MultiPlan Corporation’s management as appropriate to allow timely decisions regarding required disclosure. 

(av)  Cybersecurity; Data Protection. Except as described in the Time of Sale Information and the Offering Circular, or except as would not reasonably be expected to, individually or in the aggregate, have a Material Adverse Effect: 

(i).the Issuer and the Guarantors and their respective subsidiaries own, are licensed or otherwise have the right to use all material information technology systems used by the Issuer and the Guarantors and their respective subsidiaries in the operation of their businesses, including hardware, software, networks, and equipment (“IT Systems”);

-13-

(ii).there has been no security breach or other compromise of any of the Issuer’s, the Guarantors’ and their respective subsidiaries’ IT Systems, or the personal and proprietary information, including personal health information, stored thereon (“Data”), and the Issuer and the Guarantors and their respective subsidiaries have not been notified of, and have no knowledge of any event or condition that would reasonably be expected to result in, any security breach or other compromise to their IT Systems or Data; and

(iii).the Issuer and the Guarantors and their respective subsidiaries have implemented reasonable administrative, technical, and physical security with respect to its IT Systems and Data and comply with applicable laws with respect to the security of its IT Systems and Data.

4.     Further Agreements of the Issuer and the Guarantors.  The Issuer and each of the Guarantors jointly and severally covenant and agree with each Initial Purchaser that:
(a)Delivery of Copies.  The Issuer will deliver, without charge, to the Initial Purchasers as many copies of the Preliminary Offering Circular, any other Time of Sale Information, any Issuer Written Communication and the Offering Circular (including all amendments and supplements thereto) as the Initial Purchasers may reasonably request.
(b)Offering Circular, Amendments or Supplements.  Before finalizing the Offering Circular or making or distributing any amendment or supplement to any of the Time of Sale Information or the Offering Circular, the Issuer will furnish to the Initial Purchasers and counsel for the Initial Purchasers a copy of the proposed Offering Circular or such amendment or supplement for review, and will not distribute any such proposed Offering Circular, amendment or supplement to which the Initial Purchasers reasonably object.
(c)Additional Written Communications.  Before making, preparing, using, authorizing, approving or referring to any Issuer Written Communication, the Issuer and the Guarantors will furnish to the Initial Purchasers and counsel for the Initial Purchasers a copy of such written communication for review and will not make, prepare, use, authorize, approve or refer to any such written communication to which the Initial Purchasers reasonably object.
(d)Notice to the Initial Purchasers.  The Issuer will advise the Initial Purchasers promptly, and confirm such advice in writing, (i) of the issuance by any governmental or regulatory authority of any order preventing or suspending the use of any of the Time of Sale Information, any Issuer Written Communication or the Offering Circular or the initiation or threatening of any proceeding for that purpose; (ii) of the occurrence of any event at any time prior to the earlier of the completion of the initial offering of the Securities and 180 days after the date hereof as a result of which any of the Time of Sale Information, any Issuer Written Communication or the Offering Circular as then amended or supplemented would include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; and (iii) of the receipt by the Issuer or any of the Guarantors of any notice with respect to any suspension of the qualification of the Securities for offer and sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; and the Issuer will use its commercially reasonable efforts to prevent the issuance of any such order preventing or suspending the use of any of the Time of Sale Information, any Issuer Written Communication or the Offering Circular or suspending any such qualification of the Securities and, if any such order is issued, will use commercially reasonable efforts to obtain as soon as possible the withdrawal thereof.
(e)Time of Sale Information.  If at any time prior to the Closing Date (i) any event shall occur or condition shall exist as a result of which any of the Time of Sale Information as then amended or supplemented would include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading or (ii) it is necessary to amend or supplement any of the Time of Sale Information to 
-14-

comply with law, the Issuer will promptly notify the Initial Purchasers thereof and forthwith prepare and, subject to paragraph (b) above, furnish to the Initial Purchasers such amendments or supplements to any of the Time of Sale Information as may be necessary so that the statements in any of the Time of Sale Information as so amended or supplemented will not, in light of the circumstances under which they were made, be misleading or so that any of the Time of Sale Information will comply with law.
(f)Ongoing Compliance of the Offering Circular.  If at any time prior to the earlier of the completion of the initial offering of the Securities and 180 days after the date hereof (i) any event shall occur or condition shall exist as a result of which the Offering Circular as then amended or supplemented would include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances existing when the Offering Circular is delivered to a purchaser, not misleading or (ii) it is necessary to amend or supplement the Offering Circular to comply with law, the Issuer will promptly notify the Initial Purchasers thereof and forthwith prepare and, subject to paragraph (b) above, furnish to the Initial Purchasers such amendments or supplements to the Offering Circular as may be necessary so that the statements in the Offering Circular as so amended or supplemented will not, in the light of the circumstances existing when the Offering Circular is delivered to a purchaser, be misleading or so that the Offering Circular will comply with law.
(g)Blue Sky Compliance.  The Issuer will qualify the Securities for offer and sale under the securities or Blue Sky laws of such jurisdictions as the Initial Purchasers shall reasonably request (until the first anniversary of the date hereof) and will continue such qualifications in effect so long as required for the offering and resale of the Securities; provided that neither the Issuer nor any of the Guarantors shall be required to (i) qualify as a foreign corporation or other entity or as a dealer in securities in any such jurisdiction where it would not otherwise be required to so qualify, (ii) file any general consent to service of process in any such jurisdiction or (iii) subject itself to taxation in any such jurisdiction if it is not otherwise so subject.
(h)Clear Market.  During the period from the date hereof through and including the date that is 45 days after the date hereof, the Issuer and each of the Guarantors will not, without the prior written consent of the Representative, offer, sell, contract to sell or otherwise dispose of any debt securities issued or guaranteed by the Issuer or any of the Guarantors and having a tenor of more than one year.
(i)Supplying Information.  While the Securities remain outstanding and are “restricted securities” within the meaning of Rule 144(a)(3) under the Securities Act, the Issuer and each of the Guarantors will, during any period in which MultiPlan Corporation is not subject to and in compliance with Section 13 or 15(d) of the Exchange Act, furnish to holders of the Securities and prospective purchasers of the Securities designated by such holders, upon the request of such holders or such prospective purchasers, the information required to be delivered pursuant to Rule 144A(d)(4) under the Securities Act.
(j)DTC.  The Issuer will assist the Initial Purchasers in arranging for the Securities to be eligible for clearance and settlement through DTC.
(k)No Resales by the Issuer or the Guarantors.  During the period from the Closing Date until one year after the Closing Date, the Issuer and the Guarantors will not, and will not permit any of their respective subsidiaries to, resell any Securities that have been acquired by any of them except for Securities resold in a transaction registered under the Securities Act.
(l)No Integration.  None of the Issuer, the Guarantors or any of their respective controlled affiliates (as defined in Rule 501(b) of Regulation D) will, directly or through any agent, sell, offer for sale, solicit offers to buy or otherwise negotiate in respect of, any security (as defined in the Securities Act), that is or will be integrated with the sale of the Securities in a manner that would require registration of the Securities under the Securities Act.
-15-

(m)No General Solicitation or Directed Selling Efforts.  None of the Issuer, the Guarantors or any of their respective controlled affiliates or any other person acting on its or their behalf (other than the Initial Purchasers, as to which no covenant is given) will (i) solicit offers for, or offer or sell, the Securities by means of any form of general solicitation or general advertising within the meaning of Rule 502(c) of Regulation D or in any manner involving a public offering within the meaning of Section 4(a)(2) of the Securities Act or (ii) engage in any directed selling efforts within the meaning of Regulation S, and all such persons will comply with the offering restrictions requirement of Regulation S.
(n)No Stabilization.  None of the Issuer or any of the Guarantors will take, directly or indirectly, any action designed to or that could reasonably be expected to cause or result in any stabilization or manipulation of the price of the Securities.
(o)Perfection of Security Interests.  The Issuer and the Guarantors shall take all actions necessary to maintain such security interests in the Collateral and to perfect or secure the priority of security interests in any Collateral acquired after the Closing Date, in each case, as and to the extent contemplated by the Indenture and the Security Agreements.  
(p)Application of Use of Proceeds. The Issuer shall apply the net proceeds from the sale of the Notes as described in each of the Preliminary Offering Memorandum and the Offering Memorandum under the heading “Use of Proceeds”.
5.     Certain Agreements of the Initial Purchasers.  Each Initial Purchaser hereby represents and agrees that it has not and will not use, authorize use of, refer to, or participate in the planning for use of, any written communication that constitutes an offer to sell or the solicitation of an offer to buy the Securities other than (i) the Preliminary Offering Circular and the Offering Circular, (ii) any written communication that contains either (a) no “issuer information” (as defined in Rule 433(h)(2) under the Securities Act) or (b) “issuer information” that was included in the Time of Sale Information or the Offering Circular, (iii) any written communication listed on Schedule 3 or prepared pursuant to Section 4(c) above (including any electronic road show), (iv) any written communication prepared by such Initial Purchaser and approved by the Issuer in advance in writing or (v) any written communication relating to or that contains the terms of the Securities and/or other information that was included in the Time of Sale Information or the Offering Circular.
6.     Conditions of Initial Purchasers’ Obligations.
(i)     The obligation of each Initial Purchaser to purchase Securities on the Closing Date as provided herein is subject to the performance by the Issuer and each of the Guarantors of their respective covenants and other obligations hereunder and to the following additional conditions:
(a)Representations and Warranties.  The representations and warranties of the Issuer and the Guarantors contained herein shall be true and correct on the date hereof and on and as of the Closing Date; and the statements of the Issuer, the Guarantors and their respective officers made in any certificates delivered pursuant to this Agreement shall be true and correct on and as of the Closing Date.
(b)No Downgrade.  Subsequent to the earlier of (A) the Time of Sale and (B) the execution and delivery of this Agreement, (i) no downgrading shall have occurred in the rating accorded the Securities or any other debt securities or preferred stock issued or guaranteed by the Issuer or any of its subsidiaries by any “nationally recognized statistical rating organization,” as such term is defined by the Commission for purposes of Rule 436(g)(2) under the Securities Act; and (ii) no such organization shall have publicly announced that it has under surveillance or review, or has changed its outlook with respect to, its rating of the Securities or any other debt securities or preferred stock issued or guaranteed by the Issuer or any of its subsidiaries (other than an announcement with positive implications of a possible upgrading).
(c)No Material Adverse Change.  No event or condition of a type described in Section 3(e) hereof shall have occurred or shall exist, which event or condition is not described in each of the Time of 
-16-

Sale Information (excluding any amendment or supplement thereto) and the Offering Circular (excluding any amendment or supplement thereto) the effect of which in the judgment of the Initial Purchasers makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Securities on the terms and in the manner contemplated by this Agreement, the Time of Sale Information (excluding any amendment or supplement thereto) and the Offering Circular (excluding any amendment or supplement thereto).
(d)Officer’s Certificate.  The Initial Purchasers shall have received on and as of the Closing Date a certificate of an executive officer of the Issuer, who is satisfactory to the Initial Purchasers (i) confirming that such officer has carefully reviewed the Time of Sale Information and the Offering Circular and, to the knowledge of such officer, the representations set forth in Sections 3(a) and 3(b) hereof are true and correct, (ii) confirming that the other representations and warranties of the Issuer and the Guarantors in this Agreement are true and correct and that the Issuer and the Guarantors have complied with all agreements and satisfied all conditions on their part to be performed or satisfied hereunder at or prior to the Closing Date and (iii) to the effect set forth in paragraphs (b) and (c) above.
(e)Comfort Letters.  On the date of this Agreement and on the Closing Date, PricewaterhouseCoopers LLP shall have furnished to the Initial Purchasers, at the request of the Issuer, letters, dated the respective dates of delivery thereof and addressed to the Initial Purchasers, in form and substance reasonably satisfactory to the Initial Purchasers, containing statements and information of the type customarily included in accountants’ “comfort letters” to underwriters with respect to the financial statements and certain financial information contained in each of the Time of Sale Information and the Offering Circular; provided that the letter delivered on the Closing Date shall use a “cut-off” date no more than two business days prior to the Closing Date.
(f)Opinion and 10b-5 Statement of Counsel for the Issuer and the Guarantors.  Simpson Thacher & Bartlett LLP, counsel for the Issuer and the Guarantors, shall have furnished to the Initial Purchasers, at the request of the Issuer and the Guarantors, on the Closing Date, their written opinion and 10b-5 statement, dated the Closing Date and addressed to the Initial Purchasers, in form and substance reasonably satisfactory to the Initial Purchasers.
(g)Opinion and 10b-5 Statement of Counsel for the Initial Purchasers.  The Initial Purchasers shall have received on and as of the Closing Date an opinion and 10b-5 statement, addressed to the Initial Purchasers, of Davis Polk & Wardwell llp, counsel for the Initial Purchasers, with respect to such matters as the Initial Purchasers may reasonably request, and such counsel shall have received such documents and information as they may reasonably request to enable them to pass upon such matters.
(h)No Legal Impediment to Issuance.  No action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any federal, state or foreign governmental or regulatory authority that would, as of the Closing Date, prevent the issuance or sale of the Securities or the issuance of the Guarantees; and no injunction or order of any federal, state or foreign court shall have been issued that would, as of the Closing Date, prevent the issuance or sale of the Securities or the issuance of the Guarantees.
(i)Good Standing.  The Initial Purchasers shall have received on and as of the Closing Date satisfactory evidence of the good standing of the Issuer, the Guarantors and MultiPlan Corporation in their respective jurisdictions of organization and in such other jurisdictions as the Initial Purchasers may reasonably request, in each case, in writing or any standard form of telecommunication, from the appropriate governmental authorities of such jurisdictions.
(j)DTC.  The Securities shall be eligible for clearance and settlement through DTC.
(k)Securities.  The Securities shall have been duly executed and delivered by a duly authorized officer of the Issuer and duly authenticated by the Trustee. 
-17-

(l)Indenture.  The Indenture shall have been duly executed and delivered by a duly authorized officer of each of the Issuer, the Guarantors and the Trustee.
(m)CFO Certificate. On the date hereof and on the Closing Date, the Initial Purchasers shall have received a certificate, dated such date and signed by the Chief Financial Officer of MultiPlan Corporation, substantially in the form agreed to prior to the date hereof.
(n)Refinancing.  The Initial Purchasers shall have received evidence reasonably satisfactory to the Representative that, substantially simultaneously with the purchase of the Securities by the Initial Purchasers (i) all indebtedness outstanding pursuant to the Existing Credit Facility, and all accrued and unpaid interest, fees and other amounts owing thereunder, shall be paid in full, all commitments to extend credit under the Existing Credit Facility shall be terminated, and all liens securing obligations thereunder shall be released and (ii) the Issuer, the lenders party thereto and the New Credit Facility Agent shall have entered into the New Credit Agreement.
(o)Security Agreements.  On and as of the Closing Date, the Issuer and the Guarantors shall have entered into the Security Agreements in favor of the Notes Collateral Agent, for the benefit of the Trustee and the holders of the Securities. 
(p)Intercreditor Agreement.  On and as of the Closing Date, the Trustee, the Notes Collateral Agent and the New Credit Facility Agent shall have entered into the Intercreditor Agreement, which shall be acknowledged by the Issuer and the Guarantors, and the Initial Purchasers shall have received counterparts, conformed as executed thereof.
(q)Perfection Certificate.  The Issuer and the Guarantors shall (i) have executed and delivered a perfection certificate dated as of the Closing Date (the “Perfection Certificate”) in form and substance reasonably satisfactory to the Initial Purchasers, and (ii) have made reasonably acceptable arrangements to complete all filings and other similar actions required in connection with the perfection or priority of security interests in the Collateral as and to the extent contemplated by the Indenture and the Security Agreements on the Closing Date.
(r)UCC Financing Statements.  Unless otherwise agreed upon and subject to any exceptions permitted or contemplated by the Indenture or the Security Agreements, the Representative and the Notes Collateral Agent shall have received (i) UCC financing statements (or the equivalent filing in each other jurisdiction of the Issuer or Guarantor required to be made on the Closing Date) necessary to perfect the security interests in the Collateral (to the extent such security interests can be perfected by filing) for the benefit of the Notes Collateral Agent, the Trustee and the holders of the Securities, in form for filing in the appropriate jurisdictions, and (ii) intellectual property security agreements in form for filing in the USPTO or the USCO, as applicable, in order to perfect the security interests in the intellectual property which is part of the Collateral for the benefit of the Notes Collateral Agent, the Trustee and the holders of the Securities, in each case, with the priority required by the Security Agreements.
(s)Lien Searches.  The Representative shall have received certified copies of Uniform Commercial Code tax and judgment lien searches or equivalent reports or searches listing all effective financing statements, lien notices or comparable documents that name the Issuer or any Guarantor as debtor, none of which encumber the Collateral covered or intended to be covered by the Security Agreements (other than Permitted Liens).
(t)Stock Certificates.  Certificates representing all of the capital stock of the Issuer’s subsidiaries, to the extent certificated and required to be pledged as Collateral under the Security Agreements shall have been delivered to the New Credit Facility Agent, as required by the Security Agreements and subject to the terms of the Intercreditor Agreement and any exceptions permitted or contemplated by the Indenture and the Security Agreements. The Initial Purchasers hereby acknowledge the satisfaction of this Section 6(u).
-18-

(u)Additional Documents.  On or prior to the Closing Date, the Issuer shall have furnished to the Initial Purchasers such further certificates and documents as the Initial Purchasers may reasonably request.
All opinions, letters, certificates and evidence mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the provisions hereof only if they are in form and substance reasonably satisfactory to counsel for the Initial Purchasers.

7.     Indemnification and Contribution.
(a)Indemnification of the Initial Purchasers.  The Issuer and each of the Guarantors jointly and severally agree to indemnify and hold harmless each Initial Purchaser, its affiliates, directors and officers and each person, if any, who controls such Initial Purchaser within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, from and against any and all losses, claims, damages and liabilities (including, without limitation, legal fees and other expenses reasonably incurred in connection with any suit, action or proceeding or any claim asserted, as such fees and expenses are incurred), joint or several, that arise out of, or are based upon, any untrue statement or alleged untrue statement of a material fact contained in the Preliminary Offering Circular, any of the other Time of Sale Information, any Issuer Written Communication or the Offering Circular (or any amendment or supplement thereto) or any omission or alleged omission to state therein a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading, in each case, except insofar as such losses, claims, damages or liabilities arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with any information relating to any Initial Purchaser furnished to the Issuer in writing by such Initial Purchaser through the Representative expressly for use therein as set forth in paragraph (b) below.
(b)Indemnification of the Issuer and the Guarantors.  Each Initial Purchaser agrees, severally and not jointly, to indemnify and hold harmless the Issuer and each of the Guarantors, each of the Issuer’s and the Guarantors’ respective directors and officers and each person, if any, who controls the Issuer or the Guarantors, in each case, within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act to the same extent as the indemnity set forth in paragraph (a) above, but only with respect to any losses, claims, damages or liabilities that arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with any information relating to such Initial Purchaser furnished to the Issuer in writing by such Initial Purchaser through the Representative expressly for use in the Preliminary Offering Circular, any of the other Time of Sale Information, any Issuer Written Communication or the Offering Circular (or any amendment or supplement thereto), it being understood and agreed that the only such information consists of the following: the first sentence of the fourth paragraph, the second and third sentences of the fifth paragraph, and the statements set forth in the eighth paragraph under the heading “Plan of Distribution” in the Preliminary Offering Circular and the Offering Circular.
(c)Notice and Procedures.  If any suit, action, proceeding (including any governmental or regulatory investigation), claim or demand shall be brought or asserted against any person in respect of which indemnification may be sought pursuant to either paragraph (a) or (b) above, such person (the “Indemnified Person”) shall promptly notify the person against whom such indemnification may be sought (the “Indemnifying Person”) in writing; provided that the failure to notify the Indemnifying Person shall not relieve it from any liability that it may have under paragraph (a) or (b) above except to the extent that it has been materially prejudiced (through the forfeiture of substantive rights or defenses) by such failure; and provided, further, that the failure to notify the Indemnifying Person shall not relieve it from any liability that it may have to an Indemnified Person otherwise than under paragraph (a) or (b) above.  If any such proceeding shall be brought or asserted against an Indemnified Person and it shall have notified the Indemnifying Person thereof, the Indemnifying Person shall retain counsel reasonably satisfactory to the Indemnified Person (who shall not, without the consent of the Indemnified Person, be counsel to the Indemnifying Person) to represent the Indemnified Person and any others entitled to indemnification 
-19-

pursuant to this Section 7 that the Indemnifying Person may designate in such proceeding and shall pay the fees and expenses of such proceeding and shall pay the fees and expenses of such counsel related to such proceeding, as incurred.  In any such proceeding, any Indemnified Person shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such Indemnified Person unless (i) the Indemnifying Person and the Indemnified Person shall have mutually agreed to the contrary; (ii) the Indemnifying Person has failed within a reasonable time to retain counsel reasonably satisfactory to the Indemnified Person; (iii) the Indemnified Person shall have reasonably concluded that there may be legal defenses available to it that are different from or in addition to those available to the Indemnifying Person; or (iv) the named parties in any such proceeding (including any impleaded parties) include both the Indemnifying Person and the Indemnified Person and representation of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them.  It is understood and agreed that the Indemnifying Person shall not, in connection with any proceeding or related proceeding in the same jurisdiction, be liable for the fees and expenses of more than one separate firm (in addition to any local counsel) for all Indemnified Persons, and that all such fees and expenses shall be reimbursed as they are incurred.  Any such separate firm for any Initial Purchaser, its affiliates, directors and officers and any control persons of such Initial Purchaser shall be designated in writing by the Representative and any such separate firm for the Issuer, the Guarantors, their respective directors and officers and any control persons of the Issuer and the Guarantors shall be designated in writing by the Issuer.  The Indemnifying Person shall not be liable for any settlement of any proceeding effected without its written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the Indemnifying Person agrees to indemnify each Indemnified Person from and against any loss or liability by reason of such settlement or judgment.  Notwithstanding the foregoing sentence, if at any time an Indemnified Person shall have requested that an Indemnifying Person reimburse the Indemnified Person for fees and expenses of counsel as contemplated by this paragraph, the Indemnifying Person shall be liable for any settlement of any proceeding effected without its written consent if (i) such settlement is entered into more than 45 days after receipt by the Indemnifying Person of such request and (ii) the Indemnifying Person shall not have reimbursed the Indemnified Person in accordance with such request prior to the date of such settlement unless such Indemnifying Person has (a) paid all undisputed amounts and only failed to pay amounts disputed in good faith and (b) provided detail regarding the reasons for the failure to pay amounts requested by the Indemnifying Person.  No Indemnifying Person shall, without the written consent of the Indemnified Person, effect any settlement of any pending or threatened proceeding in respect of which any Indemnified Person is or could have been a party and indemnification could have been sought hereunder by such Indemnified Person, unless such settlement (x) includes an unconditional release of such Indemnified Person, in form and substance reasonably satisfactory to such Indemnified Person, from all liability on claims that are the subject matter of such proceeding and (y) does not include any statement as to or any admission of fault, culpability or a failure to act by or on behalf of any Indemnified Person.
(d)Contribution.  If the indemnification provided for in the above paragraphs (a) or (b) of this Section 7 is unavailable to an Indemnified Person or insufficient in respect of any losses, claims, damages or liabilities referred to therein, then each Indemnifying Person under such paragraph, in lieu of indemnifying such Indemnified Person thereunder, shall contribute to the amount paid or payable by such Indemnified Person as a result of such losses, claims, damages or liabilities (i) in such proportion as is appropriate to reflect the relative benefits received by the Issuer and the Guarantors on the one hand and the Initial Purchasers on the other from the offering of the Securities or (ii) if the allocation provided by clause (i) is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) but also the relative fault of the Issuer and the Guarantors on the one hand and the Initial Purchasers on the other in connection with the statements or omissions that resulted in such losses, claims, damages or liabilities, as well as any other relevant equitable considerations.  The relative benefits received by the Issuer and the Guarantors on the one hand and the Initial Purchasers on the other shall be deemed to be in the same respective proportions as the net proceeds (before deducting expenses) received by the Issuer from the sale of the Securities and the commissions received by the Initial Purchasers in connection therewith, as provided in this Agreement, bear to the aggregate offering price of the Securities.  The relative fault of the Issuer and the Guarantors on the one hand and the Initial Purchasers on the other shall be determined by reference to, among other things, whether the untrue or alleged untrue 
-20-

statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Issuer or any Guarantor or by the Initial Purchasers and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. 
(e)Limitation on Liability.  The Issuer and the Guarantors, and the Initial Purchasers agree that it would not be just and equitable if contribution pursuant to this Section 7 were determined by pro rata allocation (even if the Initial Purchasers were treated as one entity for such purpose) or by any other method of allocation that does not take account of the equitable considerations referred to in paragraph (d) above.  The amount paid or payable by an Indemnified Person as a result of the losses, claims, damages and liabilities referred to in paragraph (d) above shall be deemed to include, subject to the limitations set forth above, any legal or other expenses reasonably incurred by such Indemnified Person in connection with any such action or claim.  Notwithstanding the provisions of this Section 7, in no event shall an Initial Purchaser be required to contribute any amount in excess of the amount by which the total discounts and commissions received by such Initial Purchaser with respect to the offering of the Securities exceeds the amount of any damages that such Initial Purchaser has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission.  No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.  The Initial Purchasers’ obligations to contribute pursuant to this Section 7 are several in proportion to their respective purchase obligations hereunder and not joint.
(f)Non-Exclusive Remedies.  The remedies provided for in this Section 7 are not exclusive and shall not limit any rights or remedies that may otherwise be available to any Indemnified Person at law or in equity.
8.     Termination.  This Agreement may be terminated in the absolute discretion of the Representative, by notice to the Issuer, if after the execution and delivery of this Agreement and on or prior to the Closing Date (i) trading generally shall have been suspended or materially limited on the New York Stock Exchange or the Nasdaq Stock Market; (ii) trading of any securities issued or guaranteed by MultiPlan Corporation, the Issuer or any of the Guarantors shall have been suspended on any exchange or in any over-the-counter market; (iii) a general moratorium on commercial banking activities shall have been declared by federal or New York State authorities; or (iv) there shall have occurred any outbreak or escalation of hostilities or any change in financial markets or any calamity or crisis, either within or outside the United States, that, in the judgment of the Representative, is material and adverse and makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Securities on the terms and in the manner contemplated by this Agreement, the Time of Sale Information and the Offering Circular.
9.     Defaulting Initial Purchaser.
(a)If, on the Closing Date, any Initial Purchaser defaults on its obligation to purchase the Securities that it has agreed to purchase hereunder, the non-defaulting Initial Purchasers may in their discretion arrange for the purchase of such Securities by other persons satisfactory to the Issuer on the terms contained in this Agreement.  If, within 36 hours after any such default by any Initial Purchaser, the non-defaulting Initial Purchasers do not arrange for the purchase of such Securities, then the Issuer shall be entitled to a further period of 36 hours within which to procure other persons satisfactory to the non-defaulting Initial Purchasers to purchase such Securities on such terms.  If other persons become obligated or agree to purchase the Securities of a defaulting Initial Purchaser, either the nondefaulting Initial Purchasers or the Issuer may postpone the Closing Date for up to five full business days in order to effect any changes that in the opinion of counsel for the Issuer or counsel for the Initial Purchasers may be necessary in the Time of Sale Information, the Offering Circular or in any other document or arrangement, and the Issuer agrees to promptly prepare any amendment or supplement to the Time of Sale Information or the Offering Circular that effects any such changes.  As used in this Agreement, the term “Initial Purchaser” includes, for all purposes of this Agreement unless the context otherwise requires, any person not listed in 
-21-

Schedule 1 hereto that, pursuant to this Section 9, purchases Securities that a defaulting Initial Purchaser agreed but failed to purchase.
(b)If, after giving effect to any arrangements for the purchase of the Securities of a defaulting Initial Purchaser or Initial Purchasers by the non-defaulting Initial Purchasers and the Issuer as provided in paragraph (a) above, the aggregate principal amount of such Securities that remains unpurchased does not exceed one-eleventh of the aggregate principal amount of all the Securities, then the Issuer shall have the right to require each non-defaulting Initial Purchaser to purchase the principal amount of Securities that such Initial Purchaser agreed to purchase hereunder plus such Initial Purchaser’s pro rata share (based on the principal amount of Securities that such Initial Purchaser agreed to purchase hereunder) of the Securities of such defaulting Initial Purchaser or Initial Purchasers for which such arrangements have not been made.
(c)If, after giving effect to any arrangements for the purchase of the Securities of a defaulting Initial Purchaser or Initial Purchasers by the non-defaulting Initial Purchasers and the Issuer as provided in paragraph (a) above, the aggregate principal amount of such Securities that remains unpurchased exceeds one-eleventh of the aggregate principal amount of all the Securities, or if the Issuer shall not exercise the right described in paragraph (b) above, then this Agreement shall terminate without liability on the part of the non-defaulting Initial Purchasers.  Any termination of this Agreement pursuant to this Section 9 shall be without liability on the part of the Issuer or the Guarantors, except that the Issuer and each of the Guarantors will continue to be liable for the payment of expenses as set forth in Section 10 hereof and except that the provisions of Section 7 hereof shall not terminate and shall remain in effect.
(d)Nothing contained herein shall relieve a defaulting Initial Purchaser of any liability it may have to the Issuer, the Guarantors or any non-defaulting Initial Purchaser for damages caused by its default.
10.    Payment of Expenses.
(a)Whether or not the transactions contemplated by this Agreement are consummated or this Agreement is terminated, the Issuer and each of the Guarantors jointly and severally agree to pay or cause to be paid all costs and expenses incident to the performance of their respective obligations hereunder, including without limitation, (i) the costs incident to the authorization, issuance, sale, preparation and delivery of the Securities and any taxes payable in that connection; (ii) the costs incident to the preparation and printing of the Preliminary Offering Circular, any other Time of Sale Information, any Issuer Written Communication and the Offering Circular (including any amendment or supplement thereto) and the distribution thereof; (iii) the costs of reproducing and distributing each of the Transaction Documents; (iv) the fees and expenses of the Issuer’s and the Guarantors’ counsel and independent accountants; (v) the fees and expenses incurred in connection with the registration or qualification and determination of eligibility for investment of the Securities under the laws of such jurisdictions as the Initial Purchasers may designate and the preparation, printing and distribution of a Blue Sky memorandum (including the related reasonable fees and expenses of counsel for the Initial Purchasers); (vi) any fees charged by rating agencies for rating the Securities; (vii) the fees and expenses of the Trustee, the Notes Collateral Agent and any paying agent (including related reasonable fees and expenses of any counsel to such parties); (viii) all expenses and application fees incurred in connection with the approval of the Securities for book-entry transfer by DTC; (ix) costs relating to the creation, documentation or perfection of liens on the Collateral, including reasonable fees and expenses of counsel to the Initial Purchasers in connection with the creation, documentation or perfection of such liens; and (x) all expenses incurred by the Issuer and the Guarantors in connection with any “road show” presentation to potential investors; provided in the case of this clause (x) (A) the Initial Purchasers shall pay their own travel costs and expenses in connection with any “road show” and (B) the cost of any chartered aircraft used by the Issuer in connection with any “road show” presentation shall be borne 50% by the Issuer and 50% by the Initial Purchasers.
(b)If (i) this Agreement is terminated pursuant to Section 8, (ii) the Issuer for any reason fails to tender the Securities for delivery to the Initial Purchasers or (iii) the Initial Purchasers decline to 
-22-

purchase the Securities for any reason permitted under this Agreement (except that if this Agreement is terminated pursuant to Section 9, the fees and expenses of any defaulting Initial Purchaser need not be reimbursed), the Issuer agrees to reimburse the Initial Purchasers for all out-of-pocket costs and expenses (including the reasonable fees and expenses of their counsel) reasonably incurred by the Initial Purchasers in connection with this Agreement and the offering contemplated hereby.
11.    Persons Entitled to Benefit of Agreement.  This Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective successors and any controlling persons referred to herein, and the affiliates, officers and directors of each Initial Purchaser referred to in Section 7 hereof.  Nothing in this Agreement is intended or shall be construed to give any other person any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision contained herein.  No purchaser of Securities from any Initial Purchaser shall be deemed to be a successor merely by reason of such purchase.
12.    Survival.  The respective indemnities, rights of contribution, representations, warranties and agreements of (a) the Issuer and the Guarantors and (b) the Initial Purchasers contained in this Agreement or made by or on behalf of the Issuer, the Guarantors or the Initial Purchasers pursuant to this Agreement or any certificate delivered pursuant hereto shall survive the delivery of and payment for the Securities and shall remain in full force and effect, regardless of any termination of this Agreement or any investigation made by or on behalf of the Issuer, the Guarantors or the Initial Purchasers.
13.    Certain Defined Terms.  For purposes of this Agreement, (a) except where otherwise expressly provided, the term “affiliate” has the meaning set forth in Rule 405 under the Securities Act; (b) the term “business day” means any day other than a day on which banks are permitted or required to be closed in New York City; (c) the term “subsidiary” has the meaning set forth in Rule 405 under the Securities Act; and (d) the term “written communication” has the meaning set forth in Rule 405 under the Securities Act.
14.    Compliance with USA Patriot Act.  In accordance with the requirements of the USA Patriot Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)), the Initial Purchasers are required to obtain, verify and record information that identifies their respective clients, including the Issuer, which information may include the name and address of their respective clients, as well as other information that will allow the Initial Purchasers to properly identify their respective clients.
15.    Recognition of the U.S. Special Resolution Regimes. In the event that any Initial Purchaser that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer from such Initial Purchaser of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States.
In the event that any Initial Purchaser that is a Covered Entity or a BHC Act Affiliate of such Initial Purchaser becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Initial Purchaser are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States.
For purposes of this Section 15, the following definitions apply:
“BHC Act Affiliate” of a party means an “affiliate” (as such term is defined under, and interpreted in accordance with, 12 U.S.C. 1841(k)) of such party.
“Covered Entity” means any of the following:
(i)“covered entity” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 252.82(b);
(ii)a “covered bank” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 47.3(b); or
-23-

(iii)a “covered FSI” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 382.2(b).
“Default Right” has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. §§ 252.81, 47.2 or 382.1, as applicable.
“Insolvency Proceeding” means a receivership, insolvency, liquidation, resolution, or similar proceeding.
“U.S. Special Resolution Regime” means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder
16.    Miscellaneous.
(a)Authority of the Representative.  Any action by the Initial Purchasers hereunder may be taken by the Representative on behalf of the Initial Purchasers, and any such action taken by the Representative shall be binding upon the Initial Purchasers.
(b)Notices.  All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given if mailed or transmitted and confirmed by any standard form of telecommunication.  Notices to the Initial Purchasers shall be given to the Representative: c/o Goldman Sachs & Co. LLC, 200 West Street, New York, NY 10282, Attention: Registration Department. Notices to the Issuer and the Guarantors shall be given to them c/o MultiPlan Corporation, 115 Fifth Avenue New York, NY 10003; Attention: Chief Financial Officer.
(c)Entire Agreement.  This Agreement constitutes the entire agreement of the parties to this Agreement and supersedes all prior written or oral and all contemporaneous oral agreements, understandings and negotiations with respect to the subject matter hereof.
(d)Governing Law.  This Agreement and any claim, controversy or dispute arising under or related to this Agreement shall be governed by and construed in accordance with the laws of the State of New York. The Issuer and each of the Guarantors agree that any suit or proceeding arising in respect of this Agreement will be tried exclusively in the U.S. District Court for the Southern District of New York or, if that court does not have subject matter jurisdiction, in any state court located in The City and County of New York and the Issuer and each of the Guarantors agree to submit to the jurisdiction of, and to venue in, such courts.
(e)Waiver of Jury Trial.  Each of the parties hereto hereby irrevocably waives any right to trial by jury in any suit or proceeding arising out of or relating to this Agreement.
(f)Counterparts.  This Agreement may be signed in counterparts (which may include counterparts delivered by any standard form of telecommunication), each of which shall be an original and all of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.
(g)Amendments or Waivers.  No amendment or waiver of any provision of this Agreement, nor any consent or approval to any departure therefrom, shall in any event be effective unless the same shall be in writing and signed by the Issuer and the Representative.
(h)Headings.  The headings herein are included for convenience of reference only and are not intended to be part of, or to affect the meaning or interpretation of, this Agreement.
[Signature pages follow]
-24-

If the foregoing is in accordance with your understanding, please indicate your acceptance of this Agreement by signing in the space provided below.
Very truly yours,

MPH ACQUISITION HOLDINGS LLC
By:     /s/ David L. Redmond    
    Name: David L. Redmond
    Title: Executive Vice President and Chief Financial Officer
[Signature page to Purchase Agreement]

Very truly yours,

ADMAR CORPORATION
By:    /s/ David L. Redmond    
    Name: David L. Redmond
    Title: Executive Vice President and Chief Financial Officer
ASSOCIATES FOR HEALTH CARE, INC.
By:    /s/ David L. Redmond    
    Name: David L. Redmond
    Title: Executive Vice President and Chief Financial Officer
BEECH STREET CORPORATION
By:    /s/ David L. Redmond    
    Name: David L. Redmond
    Title: Executive Vice President and Chief Financial Officer
DHP ACQUISITION CORP.
By:    /s/ David L. Redmond    
    Name: David L. Redmond
    Title: Executive Vice President and Chief Financial Officer
FORMOST, INC.
By:    /s/ David L. Redmond    
    Name: David L. Redmond
    Title: Executive Vice President and Chief Financial Officer
HEALTHEOS BY MULTIPLAN, INC.
By:    /s/ David L. Redmond    
    Name: David L. Redmond
    Title: Executive Vice President and Chief Financial Officer

[Signature page to Purchase Agreement]

HEALTHNETWORK SYSTEMS LLC
By:    /s/ David L. Redmond    
    Name: David L. Redmond
    Title: Executive Vice President and Chief Financial Officer
HMA ACQUISITION CORPORATION
By:    /s/ David L. Redmond    
    Name: David L. Redmond
    Title: Executive Vice President and Chief Financial Officer
HST ACQUISITION CORP.
By:    /s/ David L. Redmond    
    Name: David L. Redmond
    Title: Executive Vice President and Chief Financial Officer
HSTECHNOLOGY SOLUTIONS, INC.
By:    /s/ David L. Redmond    
    Name: David L. Redmond
    Title: Executive Vice President and Chief Financial Officer
IHP ACQUISITION CORP.
By:    /s/ David L. Redmond    
    Name: David L. Redmond
    Title: Executive Vice President and Chief Financial Officer
LAUNCHPOINT VENTURES, LLC
By:    /s/ David L. Redmond    
    Name: David L. Redmond
    Title: Chief Executive Officer
MARS ACQUISITION CORP.
By:    /s/ David L. Redmond    
    Name: David L. Redmond
    Title: Executive Vice President and Chief Financial Officer
[Signature page to Purchase Agreement]

MEDICAL AUDIT & REVIEW SOLUTIONS, INC.
By:    /s/ David L. Redmond    
    Name: David L. Redmond
    Title: Executive Vice President and Chief Financial Officer
MPH INTERMEDIATE HOLDING COMPANY 1
By:    /s/ David L. Redmond    
    Name: David L. Redmond
    Title: Executive Vice President and Chief Financial Officer
MPI SUB, INC.
By:    /s/ David L. Redmond    
    Name: David L. Redmond
    Title: Executive Vice President and Chief Financial Officer
MULTIPLAN HOLDING CORPORATION
By:    /s/ David L. Redmond    
    Name: David L. Redmond
    Title: Executive Vice President and Chief Financial Officer
MULTIPLAN SERVICES CORPORATION
By:    /s/ David L. Redmond    
    Name: David L. Redmond
    Title: Executive Vice President and Chief Financial Officer
MULTIPLAN, INC.
By:    /s/ David L. Redmond    
    Name: David L. Redmond
    Title: Executive Vice President and Chief Financial Officer
NATIONAL CARE NETWORK, LLC
By:    /s/ David L. Redmond    
    Name: David L. Redmond
    Title: Treasurer & Secretary
[Signature page to Purchase Agreement]

NCN ACQUISITION CORPORATION
By:    /s/ David L. Redmond    
    Name: David L. Redmond
    Title: Executive Vice President and Chief Financial Officer
PRIVATE HEALTHCARE SYSTEMS, INC.
By:    /s/ David L. Redmond    
    Name: David L. Redmond
    Title: Executive Vice President and Chief Financial Officer
STATEWIDE INDEPENDENT PPO INC.
By:    /s/ David L. Redmond    
    Name: David L. Redmond
    Title: Executive Vice President and Chief Financial Officer:
TEXAS TRUE CHOICE, INC.
By:    /s/ David L. Redmond    
    Name: David L. Redmond
    Title: Executive Vice President and Chief Financial Officer
VIANT HOLDINGS, INC.
By:    /s/ David L. Redmond    
    Name: David L. Redmond
    Title: Executive Vice President and Chief Financial Officer
VIANT PAYMENT SYSTEMS, INC.
By:    /s/ David L. Redmond    
    Name: David L. Redmond
    Title: Executive Vice President and Chief Financial Officer

[Signature page to Purchase Agreement]

VIANT, INC.
By:    /s/ David L. Redmond    
    Name: David L. Redmond
    Title: Executive Vice President and Chief Financial Officer

[Signature page to Purchase Agreement]

Accepted:  August 17, 2021
For itself and on behalf of the
several Initial Purchasers listed
in Schedule 1 hereto:
GOLDMAN SACHS & CO. LLC 

By:    /s/ Trip Foley        
    Name: Trip Foley
    Title: Managing Director

[Signature page to Purchase Agreement]

Schedule 1
						
	Initial Purchaser	Principal Amount
	Goldman Sachs & Co. LLC	$245,070,000

	Barclays Capital Inc.	$244,965,000

	Citigroup Global Markets Inc.	$244,965,000

	BofA Securities, Inc.	$78,750,000

	Credit Suisse Securities (USA) LLC	$78,750,000

	Deutsche Bank Securities Inc.	$78,750,000

	UBS Securities LLC	$78,750,000

	Total	$1,050,000,000

SCH 1-1

Schedule 2
Subsidiaries
						
	Name
	Jurisdiction of Formation
	1.Admar Corporation
	California
	1.Associates for Health Care, Inc.
	Wisconsin
	1.Beech Street Corporation
	California
	1.DHP Acquisition Corp.
	Delaware
	1.ForMost, Inc.
	Delaware
	1.HealthEOS by MultiPlan, Inc.
	Wisconsin
	1.HealthNetwork Systems LLC
	Delaware
	1.HMA Acquisition Corporation
	Delaware
	1.HST Acquisition Corp.
	Delaware
	1.HSTechnology Solutions, Inc.
	Delaware
	1.IHP Acquisition Corp.
	Delaware
	1.Launchpoint Ventures, LLC
	Delaware
	1.MARS Acquisition Corp.
	Delaware
	1.Medical Audit & Review Solutions, Inc.
	Delaware
	1.MPH Intermediate Holding Company 1
	Delaware
	1.MPI Sub, Inc.
	Delaware
	1.MultiPlan Holding Corporation
	Delaware
	1.MultiPlan Services Corporation
	Delaware
	1.MultiPlan, Inc.
	New York
	1.National Care Network, LLC
	Delaware
	1.NCN Acquisition Corporation
	Delaware
	1.Private Healthcare Systems, Inc.
	Delaware
	1.Statewide Independent PPO Inc.
	New York
	1.Texas True Choice, Inc.
	Delaware
	1.Viant Holdings, Inc.
	Delaware
	1.Viant Payment Systems, Inc.
	Delaware
	1.Viant, Inc.
	Nevada
		

SCH 2-1

Schedule 3
a.    Additional Time of Sale Information
1.    Pricing Supplement containing the terms of the Securities, substantially in the form of Exhibit A.
SCH 3-1

EXHIBIT A
Pricing Supplement
[Attached]
EXHIBIT A-1

MPH ACQUISITION HOLDINGS LLC

$1,050,000,000 5.50% Senior Secured Notes due 2028
August 17, 2021
												
	Pricing Supplement
	Pricing Supplement dated August 17, 2021 to the Preliminary Offering Circular dated August 16, 2021 of MPH Acquisition Holdings LLC (as supplemented through and including the date hereof, the “Preliminary Offering Circular”).  This Pricing Supplement is qualified in its entirety by reference to the Preliminary Offering Circular.  The information in this Pricing Supplement supplements the Preliminary Offering Circular and supersedes the information in the Preliminary Offering Circular to the extent it is inconsistent with the information in the Preliminary Offering Circular. Capitalized terms used in this Pricing Supplement but not defined have the meanings given them in the Preliminary Offering Circular.
The aggregate principal amount of Notes to be issued in the offering has increased from $775,000,000 to $1,050,000,000, which represents an increase of $275,000,000 from the aggregate principal amount of Notes set forth in the Preliminary Offering Circular. See “Use of Proceeds” and “Changes to the Preliminary Offering Circular” below.

	Issuer	MPH Acquisition Holdings LLC (the “Issuer”)
	Guarantees	The Notes will be jointly and severally guaranteed on a senior secured basis by each of the Issuer’s wholly owned domestic restricted subsidiaries that guarantee the Issuer’s existing senior secured credit facilities.
	Title of Securities	5.50% Senior Secured Notes due 2028 (the “Notes”)
	Aggregate Principal Amount	$1,050,000,000
	Distribution	144A/Regulation S; no registration rights
	Maturity Date	September 1, 2028
	Issue Price	100.000%
	Coupon	5.50%. Interest will accrue from August 24, 2021.
	Benchmark Treasury	3.125% due November 15, 2028
	Benchmark Treasury Yield	1.04%
	Spread to Benchmark Treasury	+ 446 basis points
	Yield to Maturity	5.50%
	Interest Payment Dates	March 1 and September 1 of each year, beginning on March 1, 2022

												
	Record Dates	February 15 and August 15 of each year
	Trade Date	August 17, 2021
	Settlement Date	August 24, 2021
	Make-Whole Redemption	Make-whole redemption at Treasury Rate + 50 basis points prior to September 1, 2024
	Optional Redemption	On or after September 1, 2024, at the following redemption prices (expressed as a percentage of principal amount), plus accrued and unpaid interest, if any, on the Notes redeemed during the twelve-month period indicated beginning on September 1 of the years indicated below:
		Year	Price	
		2024	102.750%	
		2025	101.375%	
		2026 and thereafter	100.000%	
	Additional Redemption Right	At any time prior to September 1, 2024, we may redeem during each 12-month period commencing on the issue date up to 10% of the aggregate principal amount of the notes at a purchase price equal to 103.000% of the aggregate principal amount of the notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date.
	Equity Clawback	Up to 40% at 105.50% prior to September 1, 2024
	Change of Control	101% plus accrued and unpaid interest, if any
	Use of Proceeds	The Issuer will use the net proceeds of this offering and borrowings under its $1,325 million new senior secured term loan facility (i) to repay all of its indebtedness under its existing senior term loan facility and (ii) to pay fees and expenses in connection therewith. The Issuer will use cash on hand to repay any accrued and unpaid interest on the existing senior term loan.
	Joint Book-Running Managers	Goldman Sachs & Co. LLC
Barclays Capital Inc.
Citigroup Global Markets Inc.
BofA Securities, Inc.
Credit Suisse Securities (USA) LLC
Deutsche Bank Securities Inc.
UBS Securities LLC

	CUSIP and ISIN Numbers	Rule 144A CUSIP: 553283 AD4
Rule 144A ISIN: US553283AD43
Regulation S CUSIP: U6203K AE4
Regulation S ISIN: USU6203KAE48

2

												
	Denominations	Minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof.
	Changes to the Preliminary Offering Circular	The following changes will be made to the Preliminary Offering Circular, and other information contained in the Preliminary Offering Circular is deemed to have changed to the extent affected by the changes described below:
The amount of borrowings under the new senior secured term loan facility will equal $1,325 million.
The section of the Preliminary Offering Circular titled “Description of Notes” will be modified as follows:
Clause (24) of the exceptions to the covenant described under “Certain Covenants—Limitation on Restricted Payments” is modified as follows: 
(24) any other Restricted Payment, provided that on a pro forma basis after giving effect to such Restricted Payment the Consolidated Total Debt Ratio would be equal to or less than 4.25 4.00 to 1.0; provided, however, that at the time of, and after giving effect to, any Restricted Payment permitted under this clause (24), no Event of Default described under clause (1), (2) or (6) of the first paragraph of “—Events of Default and Remedies” shall have occurred and be continuing or would occur as a consequence thereof;
Clauses (1) and (38) of the exceptions to the covenant described under “—Limitation on Incurrence of Indebtedness and Issuance of Disqualified Stock and Preferred Stock” is modified as follows:
The foregoing limitations will not apply to:
(1) the incurrence of Indebtedness under Credit Facilities by the Company or any of the Restricted Subsidiaries and the issuance and creation of letters of credit and bankers’ acceptances thereunder (with letters of credit and bankers’ acceptances being deemed to have a principal amount equal to the face amount thereof), up to an aggregate principal amount determined at the time of incurrence not to exceed the sum of (a) $3,600.0 million plus (b) the greater of (i) $720.0 million and (ii) 1.00 multiplied by Pro Forma Consolidated EBITDA for the Applicable Measurement Period plus (c) the maximum principal amount of Secured Indebtedness that could be incurred such that, after giving effect to such incurrence, the Consolidated Secured Debt Ratio would be no greater than either (I) 5.00 4.00 to 1.00 or (II) if incurred in connection with an Acquisition or Investment, the Consolidated Secured Debt Ratio immediately prior to such Acquisition or Investment;
...
(38) Indebtedness or Disqualified Stock of the Company and Indebtedness, Disqualified Stock or Preferred Stock of any 

3

												
		Guarantor in an aggregate outstanding principal amount (when aggregated with the aggregate principal amount of Refinancing Indebtedness incurred pursuant to clause (13) above in respect of such Indebtedness then outstanding) not to exceed the amount of Restricted Payments permitted under clause (3) of the first paragraph of “— Limitation on Restricted Payments” or any of the clauses (4), (8), (10) and (24) of the second paragraph under “— Limitation on Restricted Payments,” in each case at the time of such incurrence or issuance; provided that any such Indebtedness, Disqualified Stock or Preferred Stock incurred as provided above in lieu of such Restricted Payments shall reduce availability under the applicable Restricted Payment basket under the covenant described under “—Limitation on Restricted Payments” by an amount equal to the principal amount or liquidation preference of such Indebtedness, Disqualified Stock or Preferred Stock [Reserved];
Clause (17) of the definition of “Permitted Liens” is modified as follows: 
(17) Liens securing Indebtedness permitted to be incurred under the section “— Certain Covenants — Limitation on Incurrence of Indebtedness and Issuance of Disqualified Stock and Preferred Stock”; provided that, after giving pro forma effect to the incurrence of any such Indebtedness (and any related transactions), the aggregate amount of Indebtedness then outstanding and secured thereby shall not exceed an amount equal to the sum of (i) the greater of $200.0 million and 0.35x Pro Forma Consolidated EBITDA for the Applicable Measurement Period plus (ii) an additional amount such that (A) in the case of any Indebtedness that is secured by Liens on the Collateral that constitute, or are intended to constitute, Equal Priority Obligations, the Company shall be in compliance on a pro forma basis with, at the option of the Company, a Consolidated First Lien Debt Ratio that is no greater than either (I) 5.00 4.00 to 1.00 (whether or not incurred in connection with an Acquisition or Investment) or (II) if incurred in connection with an Acquisition or Investment, the Consolidated First Lien Debt Ratio immediately prior to giving pro forma effect to such incurrence and such other transactions, (B) in the case of any Indebtedness that is secured by Liens on the Collateral that do not constitute, or are not intended to constitute, Equal Priority Obligations, the Company shall be in compliance on a pro forma basis with, at the option of the Company, (I) a Consolidated Secured Debt Ratio that is no greater than either (x) 5.00 to 1.00 (whether or not incurred in connection with an Acquisition or Investment) or (y) if incurred in connection with an Acquisition or Investment, the Consolidated Secured Debt Ratio immediately prior to giving pro forma effect to such incurrence and such other transactions or (II) a Fixed Charge

4

												
		Coverage Ratio of no less than either (x) 2.00 to 1.00 (whether or not incurred in connection with an Acquisition or Investment) or (y) if incurred in connection with an Acquisition or Investment, the Fixed Charge Coverage Ratio immediately prior to giving pro forma effect to such incurrence and such other transactions and (C) in the case of any other Indebtedness secured by Liens on assets not constituting Collateral, the Company shall be in compliance on a pro forma basis with, at the option of the Company, any of (I) a Consolidated Secured Debt Ratio of no greater than either (x) 6.50 to 1.00 (whether or not incurred in connection with an Acquisition or Investment) or (y) if incurred in connection with an Acquisition or Investment, the Consolidated Secured Debt Ratio immediately prior to giving pro forma effect to such incurrence and such other transactions (assuming, for purposes of testing the Consolidated Secured Debt Ratio pursuant to this clause (C) only, that any incurred or outstanding Liens secured by assets not constituting Collateral constitute Liens secured by Collateral) or (II) a Fixed Charge Coverage Ratio of no less than either (x) 2.00 to 1.00 (whether or not incurred in connection with an Acquisition or Investment) or (y) if incurred in connection with an Acquisition or Investment, the Fixed Charge Coverage Ratio immediately prior to giving pro forma effect to such incurrence and such other transactions, in each case, as such ratio is calculated as of the last day of the Applicable Measurement Period; provided, further, that, if such Liens are consensual Liens that are secured by the Collateral, then the Company will have the holders of the Indebtedness or other obligations secured thereby (or a representative, agent or trustee on their behalf) enter into another Customary Intercreditor Agreement providing that the consensual Liens on the Collateral (other than cash and Cash Equivalents) securing such Indebtedness or other obligations shall rank, at the option of the Company, either equal in priority (but without regard to the control of remedies) with, or junior in priority to, the Liens on the Collateral (other than cash and Cash Equivalents) securing the Secured Notes Obligations, but in any event shall not be required to enter into a Customary Intercreditor Agreement if such Liens are on Collateral consisting solely of cash and Cash Equivalents; 
The definition of “Unrestricted Subsidiary” is modified as follows: 

“Unrestricted Subsidiary” means:

(1) any Subsidiary of the Company which at the time of determination is an Unrestricted Subsidiary (as designated by the Company, as provided below); and

(2) any Subsidiary of an Unrestricted Subsidiary.

The Company may designate any Subsidiary of the Company (including any existing Subsidiary and any newly acquired or

5

												
		newly formed Subsidiary) to be an Unrestricted Subsidiary unless such Subsidiary or any of its Subsidiaries owns any Equity Interests or Indebtedness of, or owns or holds any Lien on, any property of, the Company or any Restricted Subsidiary (other than solely any Subsidiary of the Subsidiary to be so designated); provided that
(1) such designation complies with the covenants described under “— Certain Covenants —Limitation on Restricted Payments”; and

(2) each of (a) the Subsidiary to be so designated and (b) its Subsidiaries has not at the time of designation, and does not thereafter, create, incur, issue, assume, guarantee or otherwise become directly or indirectly liable with respect to any Indebtedness pursuant to which the lender has recourse to any of the assets of the Company or any Restricted Subsidiary (other than Equity Interests in the Unrestricted Subsidiary).

The Company may designate any Unrestricted Subsidiary to be a Restricted Subsidiary; provided that, immediately after giving effect to such designation, no Event of Default under clause (1), (2) or (6) of “— Events of Default” shall have occurred and be continuing and all Indebtedness of such Unrestricted Subsidiary could be incurred by a Restricted Subsidiary pursuant to the covenant entitled “— Certain Covenants — Limitation on Incurrence of Indebtedness and Issuance of Disqualified Stock and Preferred Stock” and all Liens encumbering the Capital Stock of such Unrestricted Subsidiary owned by the Company or any Restricted Subsidiary would be Permitted Liens or the provisions of the covenant entitled “— Certain Covenants — Liens” shall otherwise be complied with.

Any such designation by the Company shall be notified by the Company to the Trustee by promptly filing with the Trustee a copy of the resolution of the Board of the Company or any committee thereof giving effect to such designation and an Officer’s Certificate certifying that such designation complied with the foregoing provisions.

Unrestricted Subsidiaries may use value transferred from the Company and the Restricted Subsidiaries in an Investment permitted by the Indenture to purchase or otherwise acquire Indebtedness or Equity Interests of the Company, any Parent Entity or any Restricted Subsidiary, and to transfer value to the holders of the Equity Interests of the Company or any Restricted Subsidiary or any Parent Entity or to Affiliates thereof, and such purchase, acquisition, or transfer will not be deemed to be a “direct or indirect” action by the Company or the Restricted Subsidiaries.

6

Other information (including financial information) presented in the Preliminary Offering Circular, including any supplement thereto, is deemed to have changed to the extent affected by the changes described herein.

This material is strictly confidential and has been prepared by the Issuer solely for use in connection with the proposed offering of the securities described in the Preliminary Offering Circular. This material is personal to each offeree and does not constitute an offer to any other person or the public generally to subscribe for or otherwise acquire the securities. Please refer to the Preliminary Offering Circular for a complete description.

The securities have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), and are being offered only to (1) persons reasonably believed to be “qualified institutional buyers” as defined in Rule 144A under the Securities Act and (2) outside the United States to non-U.S. persons in compliance with Regulation S under the Securities Act, and this communication is only being distributed to such persons. 

This communication is not an offer to sell the securities and it is not a solicitation of an offer to buy the securities in any jurisdiction to any person to whom it is unlawful to make such offer or soliciation in such jurisdiction.

ANY DISCLAIMERS OR OTHER NOTICES THAT MAY APPEAR BELOW ARE NOT APPLICABLE TO THIS COMMUNICATION AND SHOULD BE DISREGARDED. SUCH DISCLAIMERS OR OTHER NOTICES WERE AUTOMATICALLY GENERATED AS A RESULT OF THIS COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHER EMAIL SYSTEM. 

7

EXHIBIT B
Restrictions on Offers and Sales Outside the United States
In connection with offers and sales of Securities outside the United States:
(a)    Each Initial Purchaser acknowledges that the Securities have not been registered under the Securities Act and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons except pursuant to an exemption from, or in transactions not subject to, the registration requirements of the Securities Act.
(b)    Each Initial Purchaser, severally and not jointly, represents, warrants and agrees that:
    (i)    Such Initial Purchaser has offered and sold the Securities, and will offer and sell the Securities, (A) as part of their distribution at any time and (B) otherwise until 40 days after the later of the commencement of the offering of the Securities and the Closing Date, only in accordance with Regulation S under the Securities Act (“Regulation S”) or Rule 144A or any other available exemption from registration under the Securities Act.
    (ii)    (A) Neither such Initial Purchaser nor any of its affiliates or any person acting on its or their behalf has engaged or will engage in any directed selling efforts (within the meaning of Regulation S) with respect to the Securities, (B) such Initial Purchaser has not entered and will not enter into any contractual arrangement with any distributor (within the meaning of Regulation S) with respect to the distribution of the Securities, except with its affiliates and (C) such Initial Purchaser and its affiliates and any person acting on its behalf have complied and will comply with the offering restrictions requirement of Regulation S.
    (iii)    At or prior to the confirmation of sale of any Securities sold in reliance on Regulation S, such Initial Purchaser will have sent to each distributor, dealer or other person receiving a selling concession, fee or other remuneration that purchases Securities from it during the distribution compliance period (within the meaning of Regulation S) a confirmation or notice to substantially the following effect:
“The Securities covered hereby have not been registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons (within the meaning of Regulation S) (i) as part of their distribution at any time or (ii) otherwise until 40 days after the later of the commencement of the offering and the date of the closing of the offering, except in either case in accordance with Regulation S or Rule 144A under the Securities Act or any other applicable exemption from registration requirements of the Securities Act.”

 (c)    Each Initial Purchaser acknowledges that no action has been or will be taken by the Issuer that would permit a public offering of the Securities, or possession or distribution of any of the Time of Sale Information, the Offering Circular, any Issuer Written Communication or any other offering or publicity material relating to the Securities, in any country or jurisdiction where action for that purpose is required.
(d)    Each Initial Purchaser, severally and not jointly, represents, warrants and agrees that:
    (i)    it has only communicated or caused to be communicated and will only communicate or cause to be communicated any invitation or inducement to engage in investment 
EXHIBIT B-1

activity (within the meaning of Section 21 of the United Kingdom Financial Services and Markets Act 2000 (the “FSMA”)) received by it in connection with the issue or sale of any Securities in circumstances in which Section 21(1) of the FSMA does not apply to the Issuer or the Guarantors; and
    (ii)    it has complied and will comply with all applicable provisions of the FSMA with respect to anything done by it in relation to the Securities in, from or otherwise involving the United Kingdom.
(e)    Each Initial Purchaser severally agrees that, in relation to each Member State of the European Economic Area which has implemented the Prospectus Directive (each, a “Relevant Member State”), with effect from and including the date on which the Prospectus Directive is implemented in that Relevant Member State (the “Relevant Implementation Date”), it has not made and will not make an offer of the Securities to the public in that Relevant Member State other than:
    (i)    to any legal entity which is a qualified investor as defined in the Prospectus Directive;
    (ii)    to fewer than 150 natural or legal persons (other than qualified investors as defined in the Prospectus Directive), as permitted under the Prospectus Directive, subject to obtaining the prior consent of the initial purchaser or the initial purchaser nominated by the Issuer for any such offer; or
    (iii)    in any other circumstances falling within Article 3(2) of the Prospectus Directive.
For the purposes of this provision, the expression an “offer of the Securities to the public” in relation to any Securities in any Relevant Member State means the communication in any form and by any means of sufficient information on the terms of the offer and the Securities to be offered so as to enable an investor to decide to purchase or subscribe the Securities, as the same may be varied in that Relevant Member State by any measure implementing the Prospectus Directive in that Relevant Member State, the expression “Prospectus Directive” means Directive 2003/71/EC (including the 2010 PD Amending Directive) and includes any relevant implementing measure in the Relevant Member State and the expression “2010 PD Amending Directive” means Directive 2010/73/EU.
EXHIBIT B-2EX-10.1

 Exhibit 10.1 

ALIGHT SOLUTIONS LLC 

AMENDED AND RESTATED EMPLOYMENT AGREEMENT 

This Amended and Restated Employment Agreement (this “Agreement”) is made as of August 18, 2021, between Alight Solutions
LLC (the “Company”) and Stephan Scholl (the “Executive”). This Agreement shall take effect as of the date it is fully executed by both parties (the
“Effective Date”). If the Effective Date does not occur for any or no reason, this Agreement shall be null and void ab initio, and the Prior Agreement (as defined below) shall remain in full force and effect in
accordance with its terms. 
 W I T N E S S E T H 

WHEREAS, the Company and the Executive previously entered into an Employment Agreement dated April 8, 2020 (the “Prior
Agreement”), which the Company and the Executive intend to replace with this Agreement;  
 WHEREAS, the Company
desires to continue to employ the Executive as the Chief Executive Officer of the Company and the Executive desires to continue to be employed by the Company on the new terms and conditions contained herein; and 

WHEREAS, this Agreement shall fully supersede the Prior Agreement. 

NOW, THEREFORE, in consideration of the foregoing, of the mutual promises contained herein and of other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows: 
 1. Position
and Duties. 
 (a) During the Employment Term (as defined in Section 2 hereof), the Executive
shall serve as the Chief Executive Officer of the Company. In this capacity, the Executive shall have the duties, authorities and responsibilities as are required by the Executive’s position, and such other duties, authorities and
responsibilities as the board of directors of the Company (the “Board”) shall designate from time to time that are not inconsistent with the Executive’s position as Chief Executive Officer of the Company. During the Employment
Term, the Executive shall devote all of the Executive’s business time, energy, business judgment, and knowledge to the performance of the Executive’s duties with the Company; provided that the foregoing shall not prevent the
Executive from (i) with the prior written approval of the Board, serving on the boards of directors of other business organizations (provided that the Executive’s service on the board of directors of each of Avaya Holdings Corp. and
1010Data, Inc., respectively, is hereby consented to and shall not require any additional written approval from the Board), (ii) participating in charitable, civic, educational, professional, community or industry affairs, and (iii) managing
the Executive’s passive personal investments, in each case so long as such activities in the aggregate do not, individually or in the aggregate, interfere or conflict with the Executive’s duties hereunder or create a fiduciary conflict.
The Executive shall report directly to Board. The Executive’s principal place of employment with the Company shall be Lincolnshire, Illinois, provided that the Executive understands and agrees that the Executive may be required to travel
from time to time for business purposes. 

 (b) As of the Effective Date, the Executive shall continue to serve as a
member of the Board. For so long as the Executive remains the Chief Executive Officer of the Company, the Board will nominate the Executive for re-election as a member of the Board. 

2. Employment Term. The Company agrees to employ the Executive pursuant to the terms of this Agreement, and the Executive agrees
to be so employed, for five (5) years (the “Initial Term”) commencing as of the Effective Date. On each anniversary of the Effective Date following the conclusion of the Initial Term, the term of this Agreement shall be
automatically extended for successive one-year periods, provided, however, that either party hereto may elect not to extend this Agreement by giving advanced written notice to the other party at
least ninety (90) days prior to any such anniversary date. Notwithstanding the foregoing, the Executive’s employment hereunder may be earlier terminated in accordance with Sections 7 and 8 hereof. The period of time between the Effective Date and the termination of the Executive’s employment hereunder shall be referred to herein as the “Employment Term”. 

3. Base Salary. The Company agrees to pay the Executive a base salary at an annual rate of $800,000, payable in accordance with the
regular payroll practices of the Company. The Executive’s base salary shall be subject to annual review by the Board (or a committee thereof), and may be increased (but not decreased) from time to time by the Board. The base salary as
determined herein and as may be increased from time-to-time shall constitute “Base Salary” for purposes of this Agreement. 

4. Annual Bonus. For each calendar year that ends during the Executive’s employment, the Executive shall be eligible to receive an
annual incentive payment (the “Annual Bonus”) based on a target bonus opportunity of 200% of Base Salary (the “Target Bonus”) with greater or lesser amounts paid for performance above and below target, based upon
the attainment of one or more objective performance goals established by the Board (or a committee thereof) after consultation with the Executive. The performance criteria for any particular year shall be provided to the Executive no later than
sixty (60) days following the approval by the Board (or a committee thereof). Annual Bonuses, to the extent earned, will be paid consistent with the timing of when bonuses are paid by the Company under the Company’s Annual Incentive Plan
to which the applicable Annual Bonus relates. Except as otherwise provided in Section 8, payment of any Annual Bonus is contingent upon the Executive’s employment through the applicable bonus payment date. 

5. Equity. Notwithstanding anything set forth in any other plan, program, arrangement or agreement to the contrary, the equity-based
incentive award granted to Executive in connection with the close of the Business Combination on July 2, 2021 (“Initial Grant”) shall immediately vest in full upon a Change in Control, subject to Executive’s continued employment
on the date of the Change in Control; provided that if Executive’s employment is terminated by the Company without Cause or by the Executive with Good Reason, in either case, in the six (6) month period preceding a Change in Control, the
Executive shall be deemed employed as of the date of the Change in Control for purposes of this paragraph. “Change in Control” shall mean a “change in control event” with respect to the Company for purposes of Code
Section 409A. All equity awards other than the Initial Grant shall vest in accordance with the award agreement and plan governing the grant. 

  
 2 

 6. Executive Benefits. 

(a) Benefit Plans. During the Employment Term, the Executive shall be eligible to participate in the employee benefit
programs maintained by the Company from time to time, subject to satisfying the applicable eligibility requirements, except to the extent such plans are duplicative of the benefits otherwise provided hereunder. The Executive’s participation
will be subject to the terms of the applicable plan documents and generally applicable Company policies. Notwithstanding the foregoing, the Company may amend, modify, or terminate any employee benefit plan at any time. 

(b) Vacations. During the Employment Term, the Executive shall be entitled to paid vacation time in accordance with the
Company’s policy as in effect from time to time. 
 (c) Flight Reimbursement. During the Employment Term, the
Executive shall be permitted to utilize private aviation for business related purposes for up to 200 flight hours per year, and the Company shall reimburse the Executive for the costs of such private aviation up to an annual average of $6,700 per
hour for up to 200 flight hours per year; provided that, the Executive will be required to submit to the Company verification, substantiation and documentation setting forth the nature and cost of such private aviation expenses in accordance with
the policies of the Company from time to time. In addition, the Executive shall be entitled to travel first class on any commercial flight for business purposes at the Company’s expense, subject to availability of such first class tickets and
upon presentation of reasonable substantiation and documentation as the Company may specify from time to time. 
 (d)
Business and Entertainment Expenses. Upon presentation of reasonable substantiation and documentation as the Company may specify from time to time, the Executive shall be reimbursed in accordance with the Company’s expense reimbursement
policy, for all reasonable out-of-pocket business, travel and entertainment expenses incurred and paid by the Executive during the Employment Term in connection
with the performance of the Executive’s duties hereunder. 
 (e) Work Authorization. The parties hereto shall
take all reasonably required steps to obtain and maintain any work permit or other authorization for the Executive that is necessary for the Executive to provide services pursuant to Section 1 hereof and continue to be
employed in the United States. The Company will pay (or reimburse to the Executive on a net after-tax basis) all expenses associated with obtaining and retaining work permits and authorizations, and for the
Executive and his family in applying for permanent resident status in the United States. 

  
 3 

 (f) Indemnification. The Company hereby agrees to indemnify the
Executive and hold the Executive harmless to the maximum extent permitted under Delaware law and provided for under the organizational documents of the Company against and in respect of any and all actions, suits, proceedings, claims, demands,
judgments, costs, expenses (including reasonable attorney’s fees), losses, and damages resulting from the Executive’s good faith performance of the Executive’s duties and obligations with the Company. The Company will procure and
maintain Directors & Officers liability insurance that covers the Executive at a level no less than that provided to any other officer or director of the Company. The foregoing obligations shall survive during the Employment Term plus the
applicable statute of limitations period. 
 7. Termination. The Executive’s employment and the Employment Term shall terminate
on the first of the following to occur: 
 (a) Disability. Upon ten (10) days’ prior written notice by the
Company to the Executive of termination due to Disability. For purposes of this Agreement, “Disability” shall mean “disability” pursuant to the standards set forth in, or in circumstances where the Executive qualifies for
receipt of benefits under, the long-term disability plan of the Company and/or its subsidiaries. The Executive shall cooperate in all respects with the Company if a question arises as to whether the Executive has become disabled (including, without
limitation, submitting to reasonable examinations by one or more medical doctors and other health care specialists selected by the Company and authorizing such medical doctors and other health care specialists to discuss the Executive’s
condition with the Company). 
 (b) Death. Automatically upon the date of death of the Executive. 

(c) Cause. Immediately upon written notice by the Company to the Executive of a termination for Cause.
“Cause” shall mean (i) performing an act of fraud, theft, embezzlement or willful misappropriation involving the Executive’s employment with or service to the Company, or any of its subsidiaries or affiliates;
(ii) performing an act of race, sex, national origin, religion, disability, or age based discrimination in violation of any Company policy or applicable law, which after an independent investigation, counsel to the Company reasonably concludes
will result in liability being imposed on the Company, or any of its subsidiaries or affiliates or the Executive; (iii) the Executive’s material violation of the Company’s or any of its subsidiaries’ or affiliates’ material
written policies and procedures including, but not limited to, the Company’s Code of Conduct; (iv) the Executive’s material noncompliance with the terms of this Agreement, or of any material agreement with the Company or any of its
affiliates or subsidiaries containing, covenants regarding non-competition, non-solicitation, non-disparagement and/or non-disclosure obligations; or (v) performing any criminal act resulting in a criminal felony charge being brought (provided such charges are not dropped or otherwise reduced to a charge that does not meet
these standards within sixty (60) days) against the Executive or the Executive’s criminal conviction of a crime of moral turpitude (other than conviction of a minor traffic violation); provided that no such determination may be made under
clauses (iii) or (iv) above until the Executive has been given written notice detailing the specific Cause event and a period of thirty (30) days following receipt of such notice to cure such event, but only to the extent the specific
Cause event is actually curable. Notwithstanding the foregoing, any action or inaction taken by the Executive based upon the Executive’s reasonable reliance on advice of counsel to the Company or the direction of the Board shall not form the
basis for Cause. 

  
 4 

 (d) Without Cause. Immediately upon written notice by the Company to
the Executive of an involuntary termination without Cause (other than for death or Disability). 
 (e) Good Reason.
Upon written notice by the Executive to the Company of a termination for Good Reason. “Good Reason” shall mean (i) a reduction in the Executive’s Base Salary or Target Bonus, (ii) a relocation of the Executive’s
primary place of employment by more than fifty (50) miles from its then current location, (iii) the Company’s material breach of the terms of this Agreement, or of any material agreement between the Company or any of its affiliates
and Executive, or (iv) a reduction in title or a material demotion in the Executive’s duties, authorities, or responsibilities, in each case, without the Executive’s written consent; provided that such reduction shall not constitute
“Good Reason,” unless the Executive notifies the Company within thirty (30) days following the initial occurrence of such event, and the Company fails to reverse such event within thirty (30) days of the Company’s receipt of
such notice. In order to invoke a termination for “Good Reason,” the Executive must terminate his employment, if at all, within ninety (90) days following the initial occurrence of the “Good Reason” event. 

(f) Without Good Reason. Upon ninety (90) days’ prior written notice by the Executive to the Company of the
Executive’s voluntary termination of employment without Good Reason (which the Company may, in its sole discretion, make effective earlier than any notice date). 

(g) Expiration of Employment Term; Non-Extension of Agreement. Upon the
expiration of the Employment Term due to a non-extension of the Agreement by the Company or the Executive pursuant to the provisions of Section 2 hereof.  
 8. Consequences of Termination. 

(a) Death. In the event the Executive’s employment is terminated due to Executive’s death, the Company shall
pay or provide to the Executive or the Executive’s estate, as the case may be, the amounts set forth below within sixty (60) days following termination of employment (or such earlier date as may be required by applicable law)
(collectively, Sections 8(a)(i) through 8(a)(v) hereof shall be hereafter referred to as the “Accrued Amounts”). 

(i) Any Base Salary earned, but not yet paid by the Company, through date of the Executive’s termination with the Company
(such date, the “Termination Date”); 
 (ii) any Annual Bonus earned under the Company’s Annual
Incentive Plan, but not yet paid by the Company, with respect to a year ending on or preceding the Termination Date; 
 (iii)
any accrued but unused vacation time in accordance with the Company’s policy as in effect from time to time; 

  
 5 

 (iv) reimbursement for any unreimbursed business expenses incurred through
the Termination Date, provided that such expenses and required substantiation and documentation are submitted within 30 days following such termination and reimbursement under the Company’s policy; and 

(v) all other payments, benefits, or fringe benefits to which the Executive shall be entitled under the terms of any applicable
compensation arrangement or benefit, equity or fringe benefit plan or program or grant or this Agreement. 
 (b)
Disability. In the event that the Executive’s employment and/or Employment Term ends on account of the Executive’s Disability, the Company shall pay or provide the Executive with the Accrued Amounts. 

(c) Termination for Cause or Without Good Reason or as a Result of Executive
Non-Extension of this Agreement. If the Executive’s employment is terminated (x) by the Company for Cause, (y) by the Executive without Good Reason, or (z) as a result of the
Executive’s non-extension of the Employment Term as provided in Section 2 hereof, the Company shall pay to the Executive the Accrued Amounts other than the benefit described in
Section 8(a)(ii) hereof. 
 (d) Termination Without Cause or for Good Reason or as a Result of
Company Non-Extension of this Agreement. If the Executive’s employment by the Company is terminated (x) by the Company other than for Cause (and not due to the Executive’s death or
Disability) or (y) by the Executive for Good Reason, the Company shall pay or provide the Executive with the following, below, subject to Executive’s continued compliance with the terms of this Agreement (including Executive’s timely
execution and non-revocation of the release as set forth in Section 8(e) herein and continued compliance with Sections 9 and 10): 

(i) An amount equal to two (2) times the sum of (i) the Executive’s Base Salary (at the highest rate in effect
in the six (6) month period preceding the Termination Date) and (ii) the Executive’s average Annual Bonus over the two most recent full completed fiscal years immediately preceding the fiscal year in which the Termination Date occurs
(provided that, (x) if the Executive was not employed by the Company during each of the two full completed fiscal years immediately preceding the fiscal year in which the Termination Date occurs, the amount shall be determined based on the
Executive’s average annualized Annual Bonus received in respect of the fiscal years in which the Executive was employed); and (y) if the Executive has not received an Annual Bonus for a full completed fiscal year at any time prior to the
Termination Date due to having been a new hire, the amount shall be determined by reference to the Executive’s target annual cash incentive opportunity), payable in substantially equal installments in accordance with the Company’s normal
payroll policies commencing on the first payroll period following the date on which the Release (as defined in Section 8(e) herein) is executed and no longer subject to revocation, and continuing for twenty-four
(24) consecutive months thereafter; 

  
 6 

 (ii) a pro-rata portion of the
Executive’s Annual Bonus for the year in which the Termination Date occurs based on actual results for such year (determined by multiplying the amount of such bonus which would be due for the full year by a fraction, the numerator of which is
the number of full or partial months during the applicable year that the Executive is employed by the Company and the denominator of which is twelve (12)), payable in accordance with Section 4 hereof; 

(iii) subject to (A) the Executive’s timely election of continuation coverage under the Consolidated Omnibus Budget
Reconciliation Act of 1985, as amended (“COBRA”), (B) the Executive’s continued copayment of premiums at the same level and cost to the Executive as if the Executive were an employee of the Company (excluding, for purposes of
calculating cost, an employee’s ability to pay premiums with pre-tax dollars), and (C) the Executive’s continued compliance with the obligations in Sections 9 and 10 hereof,
continued participation in the Company’s group health plan (to the extent permitted under applicable law and the terms of such plan) which covers the Executive (and the Executive’s eligible dependents) for a period of twelve
(12) months at the Company’s expense, provided that the Executive is eligible and remains eligible for COBRA coverage; provided, further, that the Company may modify the continuation coverage contemplated by this
Section 8 to the extent reasonably necessary to avoid the imposition of any excise taxes on the Company for failure to comply with the nondiscrimination requirements of the Patient Protection and Affordable Care Act of
2010, as amended, and/or the Health Care and Education Reconciliation Act of 2010, as amended (to the extent applicable); and provided, further, that in the event that the Executive obtains other employment that offers group health benefits, such
continuation of coverage by the Company under this Section 8 shall immediately cease; and 
 (iv)
for twelve (12) months following the Termination Date, the Executive will have access to Company provided outplacement services at a level commensurate with the Executive’s position in accordance with the Company’s practices as in
effect from time to time. 
 (e) Notwithstanding any provision in this Agreement to the contrary, the Executive hereby agrees
that the Company’s obligations to provide the payments set forth in Section 8(d) herein (such payments, the “Severance Payments”) shall be conditioned upon the Executive’s execution and
nonrevocation of, and compliance with, the Company’s release of claims contained in Exhibit A to this Agreement, as modified in the Company’s sole discretion to preserve the enforceability of such agreement under applicable local law (the
“Release”), within twenty-eight (28) days of the Executive’s Termination Date and the Executive’s continued compliance with any other existing non-competition, non-solicitation of clients and employees, and confidentiality agreements between the Executive and the Company. Any Severance Payments payable under this Agreement shall not be paid until the first scheduled
payment date following the date the Release is executed and no longer subject to revocation, with the first such payment being in an amount equal to the total amount to which the Executive would otherwise have been

  
 7 

 
entitled during the period following the Termination Date if such deferral had not been required; provided, however, that any such amounts that constitute nonqualified deferred compensation
within the meaning of Internal Revenue Code Section 409A and the regulations and guidance promulgated thereunder (“Section 409A”) shall not be paid until the 28th day following such termination to the extent
necessary to avoid adverse tax consequences under Section 409A, and, if such payments are required to be so deferred, the first payment shall be in an amount equal to the total amount to which the Executive would otherwise have been entitled
during the period following the Termination Date if such deferral had not been required; provided further that a termination of employment shall not be deemed to have occurred for purposes of any provision of this Agreement providing for the payment
of any amount or benefit upon or following a termination of employment unless such termination is also a “separation from service” within the meaning of Section 409A and, for purposes of any such provision of this Agreement,
references to a “termination,” “termination of employment” or like terms shall mean “separation from service”, and if the Executive is deemed a “specified employee” within the meaning of Section 409A on
the Termination Date, then any Severance Payments payable to the Executive under this Agreement during the first six months and one day following the Termination Date that constitute nonqualified deferred compensation within the meaning of
Section 409A shall not be paid until the date that is six (6) months and one day following such termination to the extent necessary to avoid adverse tax consequences under Section 409A, and, if such payments are required to be so
deferred, the first payment shall be in an amount equal to the total amount to which the Executive would otherwise have been entitled to during the period following the Termination Date if such deferral had not been required. 

(f) In no event shall the Executive be obligated to seek other employment or take any other action by way of mitigation of the
amounts payable to the Executive under any of the provisions of this Agreement, nor shall the amount of any payment hereunder be reduced by any compensation earned by Executive as a result of employment by a subsequent employer, other than as set
forth in Section 8(d)(iii). The Company’s obligations to pay the Executive amounts hereunder shall not be subject to set-off, counterclaim or recoupment of amounts owed by
Executive to the Company or any of its affiliates. 
 9. Restrictive Covenants. The Executive acknowledges and recognizes the highly
competitive nature of the business of the Company, and accordingly agrees to the following restrictive covenants. 
 (a) Non-Competition; Non-Solicitation; Non-Disparagement. 

(i) the Executive acknowledges and recognizes the highly competitive nature of the businesses of the Company and its
subsidiaries, and accordingly agrees as follows: 

  
 8 

 (1) During the Employment Term and for a period of two (2) years
following the date the Executive ceases to be employed by the Company (together, the “Restricted Period”), the Executive will not, whether on the Executive’s own behalf or on behalf of or in conjunction with any person, firm,
partnership, joint venture, association, corporation or other business organization, entity or enterprise whatsoever (for the purposes of this Section 9, a “Person”), directly or indirectly solicit or
assist in soliciting any business of the same type or kind as the Covered Business performed by the Restricted Group from or with respect to (A) clients or customers of the Restricted Group with respect to whom the Executive provided services,
either alone or with others, or had a business relationship, or on whose account the Executive worked or became familiar, or supervised directly or indirectly the servicing activities with respect to that client or customer, during the twenty-four
month period prior to the Executive’s Termination Date, and further provided such clients or customers were clients or customers of the Restricted Group either on such Termination Date or during the twenty-four months prior thereto, and
(B) prospective clients or customers of the Restricted Group which the Executive alone, in combination with others, or in a supervisory capacity, solicited during the eighteen months prior to the Executive’s Termination Date.
Notwithstanding the foregoing, the provisions of this Section 9(a)(i) shall not be violated by (A) general advertising or solicitation not specifically targeted at Company-related persons or entities, (B) the
Executive serving solely as a reference, upon request, for any employee of the Company Group, or (C) actions taken by any person or entity with which the Executive is associated if the Executive is not directly or indirectly involved in the
matter and has not directly or indirectly identified such Company-related person or entity for soliciting or hiring. 
 (2)
During the Restricted Period, the Executive will not directly or indirectly, as an individual, partner, shareholder, officer, director, principal, agent, trustee or consultant: 

a. engage in, or acquire a financial interest in or otherwise become actively involved with any Person engaged in, the Covered
Business within any country where the Restricted Group engages, or plans to engage, in the Covered Business as of the Executive’s Termination Date; or 

b. intentionally and adversely interfere with, or intentionally attempt to adversely interfere with, business relationships
between the members of the Restricted Group and any of their clients, customers, suppliers, partners, members or investors. 

(3) Notwithstanding anything to the contrary in this Section 9, the Executive may, directly or
indirectly own, solely as an investment, securities of any Person engaged in the Covered Business which are publicly traded on a national or regional stock exchange or on the
over-the-counter market if the Executive (A) is not a controlling person of, or a 

  
 9 

 
member of a group which controls, such person and (B) does not, directly or indirectly, own 2% or more of any class of securities of such Person. In addition, the provisions of this
Section 9 shall not be violated by the Executive, during the portion of the Restricted Period commencing after the Employment Term, commencing employment with, or providing services to, a portfolio company of a private
equity or financial sponsor that owns, invests in, or operates a business that engages in a Covered Business or otherwise commencing employment with, or providing services to, a subsidiary, division or unit of any entity that engages in a Covered
Business, in each case, so long as (i) the Executive does not directly or indirectly perform services (including advisory services) for the entity that is engaged in the Covered Business and (ii) such activities do not interfere or
conflict with the Executive’s duties hereunder or create a fiduciary conflict. 
 (4) During the Restricted Period, the
Executive will not, whether on the Executive’s own behalf or on behalf of or in conjunction with any Person, directly or indirectly: 

a. solicit or encourage any employee of the Restricted Group to leave the employment of the Restricted Group; 

b. hire any executive-level employee (i.e., vice president level and above or equivalent title ) who was employed by the
Restricted Group as of the Executive’s Termination Date or who left the employment of the Restricted Group coincident with, or within one (1) year prior to, or after, the Executive’s Termination Date, excluding an executive-level
employee whose employment with the Restricted Group ceased at least twelve months prior to the date of such hiring; or 
 c.
encourage any consultant of the Restricted Group to cease working with the Restricted Group. 
 (5) For purposes of this
Section 9: 
 a. “Covered Business” means (1) developing and implementing software
and services solutions for, and providing (x) health and welfare (including participant advocacy, healthcare navigation, reimbursement accounts, Medicare enrollment services and other ancillary point solutions services) and retirement
(including any defined contribution participant financial advisory and self-directed brokerage account services and other ancillary point solutions services) benefits administration services and (y) hosted and cloud-based human resources
business process outsourcing administration and implementation services (including payroll processing, HR data management services, cloud advisory, deployment and application management services for cloud human

  
 10 

 
capital management and financial platforms, (2) human resource and other related communications consulting services, and/or (3) such businesses (not described in (1) or (2) above)
in which the Restricted Group engages or has plans to engage (as evidenced by the investment of time or resources therein), in each case, as of the Executive’s Termination Date. . 

b. “Restricted Group” means, collectively, the Company and its subsidiaries. 

(ii) During the Employment Term and at all times thereafter, the Executive agrees not to make, or cause any other person to
make, any communication that is intended to disparage, or has the effect of disparaging, the Company or its affiliates, subsidiaries, agents, shareholders, members, or advisors (or any of its or their respective employees, officers or directors, it
being understood that communication made in the Executive’s good faith performance of the Executive’s duties hereunder shall not be deemed disparaging for purposes of this Agreement). The Company agrees to instruct the Board and the
Restricted Group’s executives (and use commercially reasonable efforts to ensure compliance with such instruction) not to make negative comments about the Executive or otherwise disparage the Executive in any manner that is likely to be harmful
to the Executive’s business reputation. Nothing set forth herein shall be interpreted to prohibit the Executive and the Restricted Group (or their respective executives), or members of the Board from responding truthfully to incorrect public
statements, making truthful statements when required by law, subpoena or court order and/or from responding to any inquiry by any regulatory or investigatory organization. 

(b) Confidentiality; Intellectual Property. 

(i) Confidentiality. 

(1) The Executive will not at any time (whether during the Employment Term or thereafter) (A) retain or use for the
benefit, purposes or account of the Executive or any other Person; or (B) disclose, divulge, reveal, communicate, share, transfer or provide access to any Person outside the Company and its affiliates (other than the Executive’s
professional advisers who are bound by confidentiality obligations or otherwise in performance of the Executive’s duties under the Executive’s employment and pursuant to customary industry practice), any
non-public, proprietary or confidential information — including without limitation trade secrets, know-how, research and development, software, databases,
inventions, processes, formulae, technology, designs and other intellectual property, information concerning finances, investments, profits, pricing, costs, products, services, vendors, customers, clients, partners, investors, personnel,
compensation, recruiting, training, advertising, sales, marketing, promotions, government and regulatory activities and approvals — concerning the past, current or future business, activities and operations of the Company or any of its
affiliates and/or any third party that has disclosed or provided any of same to the Company or any of its affiliates or Subsidiaries on a confidential basis (“Confidential Information”), without the prior written authorization of
the Board. 

  
 11 

 Notwithstanding the foregoing, the Executive may deliver or disclose Confidential
Information to any federal or state regulatory authority having jurisdiction over the Executive to the extent required in connection with any audit or other legal proceeding by such authority, or to any court, arbitrator, or other tribunal
(x) in response to any subpoena or other legal compulsory process or (y) in the enforcement of the Executive’s rights and remedies under this Agreement or any other agreement with the Restricted Group; provided, that the
Executive will (to the extent legally permissible) promptly notify the Company in advance so that the Company may seek (at its own expense) a protective order or other appropriate remedy or waive compliance with this
Section 9(b). 
 (2) “Confidential Information” shall not include any information that
is (A) generally known to the industry or the public other than as a result of the Executive’s breach of this covenant; (B) made legitimately available to the Executive by a third party without breach of any confidentiality obligation
of which the Executive has knowledge; or (C) required by law to be disclosed; provided that with respect to subsection (C) the Executive shall give prompt written notice to the Company of such requirement, disclose no more information than
is so required, and reasonably cooperate with any attempts by the Company to obtain a protective order or similar treatment. 

(3) Except as required by law, the Executive will not disclose to anyone, other than the Executive’s family (it being
understood that, in this Agreement, the term “family” refers to the Executive, the Executive’s spouse, children, parents and spouse’s parents) and advisors, the existence or contents of this Agreement; provided that the Executive
may disclose to any prospective future employer the provisions of this Section 9. Subsection (b)(i)(3) of this Section 9 shall terminate if any member of the Restricted Group publicly discloses a
copy of this Agreement (or, publicly discloses summaries or excerpts of this Agreement, to the extent so disclosed). 
 (4)
Upon termination of the Executive’s employment with the Company for any reason, the Executive shall (A) cease and not thereafter commence use of any Confidential Information or intellectual property (including without limitation, any
patent, invention, copyright, trade secret, trademark, trade name, logo, domain name or other source indicator) owned or used by the Company or its affiliates; and (B) immediately destroy, delete, or return to the Company, at the Company’s
option, all originals and copies in any form or medium (including memoranda, books, papers, plans, 

  
 12 

 
computer files, letters and other data) in the Executive’s possession or control (including any of the foregoing stored or located in the Executive’s office, home, laptop or other
computer, whether or not Company property) that contain Confidential Information, except that the Executive may retain only those portions of any personal notes, notebooks and diaries that do not contain any Confidential Information. 

(5) 18 U.S.C. § 1833(b) provides: “An individual shall not be held criminally or civilly liable under any Federal or
State trade secret law for the disclosure of a trade secret that (A) is made (x) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and (y) solely for the purpose of
reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.” Nothing in this Agreement is intended to conflict with 18
U.S.C. § 1833(b) or create liability for disclosures of trade secrets that are expressly allowed by 18 U.S.C. § 1833(b). Accordingly, the parties to this Agreement have the right to disclose in confidence trade secrets to federal, state,
and local government officials, or to an attorney, for the sole purpose of reporting or investigating a suspected violation of law. The parties also have the right to disclose trade secrets in a document filed in a lawsuit or other proceeding, but
only if the filing is made under seal and protected from public disclosure. 
 (6) Nothing in this Agreement shall prohibit
or restrict the Executive from, or shall be interpreted so as to impede the Executive (or any other individual) from, reporting possible violations of federal law or regulation to any governmental agency or entity, including but not limited to the
Department of Justice, the Securities and Exchange Commission, the Congress, and any agency Inspector General, or making other disclosures under the whistleblower provisions of federal law or regulation. The Executive does not need the prior
authorization of the Company to make any such reports or disclosures, and the Executive shall not be required to notify the Company that such reports or disclosures have been made. 

(ii) Intellectual Property. 

(1) If the Executive creates, invents, designs, develops, contributes to or improves any works of authorship, inventions,
intellectual property, materials, documents or other work product (including without limitation, research, reports, software, databases, systems, applications, presentations, textual works, content, or audiovisual materials)
(“Works”), either alone or with third parties, at any time during the Executive’s employment by the Company and within the scope of such employment and/or with the use of any resources of Company or any of its affiliates
(“Alight Works”), the Executive shall promptly and fully disclose same to the Company and hereby irrevocably assigns, transfers and conveys, to the 

  
 13 

 
maximum extent permitted by applicable law, all of the Executive’s right, title, and interest therein (including rights under patent, industrial property, copyright, trademark, trade secret,
unfair competition, other intellectual property laws, and related laws) to the Company to the extent ownership of any such rights does not vest originally in the Company. If the Executive creates any written records (in the form of notes, sketches,
drawings, or any other tangible form or media) of any Alight Works, the Executive will keep and maintain same. The records will be available to and remain the sole property and intellectual property of the Company at all times. 

(2) The Executive shall take all requested actions and execute all requested documents (including any licenses or assignments
required by a government contract) at the Company’s expense (but without further remuneration) to assist the Company in validating, maintaining, protecting, enforcing, perfecting, recording, patenting or registering any of the rights of the
Company or its affiliates in the Alight Works. 
 (3) The Executive shall not improperly use for the benefit of, bring to
any premises of, divulge, disclose, communicate, reveal, transfer or provide access to, or share with the Company or any of its affiliates any confidential, proprietary or non-public information or
intellectual property relating to a former employer or other third party without the prior written permission of such third party. The Executive shall comply with all relevant policies and guidelines of the Company and its affiliates that are from
time to time previously disclosed to the Executive, including regarding the protection of Confidential Information and intellectual property and potential conflicts of interest. 

(4) The provisions of subsection (b) of this Section 9 hereof shall survive the termination of
the Executive’s employment for any reason. 
 (c) Reasonableness of Covenants. In signing this Agreement, the
Executive gives the Company assurance that the Executive has carefully read and considered all of the terms and conditions of this Agreement, including the restraints imposed under this Section 9. The Executive agrees that
these restraints are necessary for the reasonable and proper protection of the Company and its affiliates and their trade secrets and confidential information and that each and every one of the restraints is reasonable in respect to subject matter,
length of time and geographic area, and that these restraints, individually or in the aggregate, will not prevent the Executive from obtaining other suitable employment during the period in which the Executive is bound by the restraints. The
Executive acknowledges that each of these covenants has a unique, very substantial and immeasurable value to the Company and its affiliates and that the Executive has sufficient assets and skills to provide a livelihood while such covenants remain
in force. The Executive further covenants that the Executive will not challenge the reasonableness or enforceability of any of the covenants set forth in this Section 9. It is also agreed that the Company’s affiliates
will have the right to enforce all of the Executive’s obligations to such affiliates under this Agreement, including, without limitation, pursuant to this Section 9. 

  
 14 

 (d) Reformation. If it is determined by a court of competent
jurisdiction in any state that any restriction in this Section 9 is excessive in duration or scope or is unreasonable or unenforceable under applicable law, it is the intention of the parties that such restriction may be
modified or amended by the court to render it enforceable to the maximum extent permitted by the laws of that state. 
 (e)
Tolling. In the event of any violation of the provisions of this Section 9, the Executive acknowledges and agrees that the post-termination restrictions contained in this Section 9 shall be
extended by a period of time equal to the period of such violation, it being the intention of the parties hereto that the running of the applicable post-termination restriction period shall be tolled during any period of such violation. 

(f) Remedies. The Executive acknowledges and agrees that the Company’s remedies at law for a breach or threatened
breach of any of the provisions of this Section 9 would be inadequate and, in recognition of this fact, the Executive agrees that, in the event of such a breach or threatened breach, in addition to any remedies at law, the
Company, without posting any bond or other security, shall be entitled to obtain equitable relief in the form of specific performance, a temporary restraining order, a temporary or permanent injunction or any other equitable remedy which may then be
available, without the necessity of showing actual monetary damages. 
 (g) Survival. The Executive’s obligations
under Section 9 of this Agreement shall survive the termination of Executive’s employment with the Company for any reason and shall thereafter be enforceable whether or not such termination is found to be wrongful or
to constitute or result in a material breach of any contract, including, but not limited to, a breach of any employment contract or of any other material duty owed or claimed to be owed to the Executive by the Company or any Company employee, agent
or contractor. 
 10. Cooperation. Upon the receipt of reasonable notice from the Company (including outside counsel), the Executive
agrees that while employed by the Company and for the five (5) year period thereafter, the Executive will respond and provide information with regard to matters in which the Executive has knowledge as a result of the Executive’s employment
with the Company, and will provide reasonable assistance to the Company, its affiliates and their respective representatives in defense of any claims that may be made against the Company or its affiliates, and will assist the Company and its
affiliates in the prosecution of any claims that may be made by the Company or its affiliates, to the extent that such claims may relate to the period of the Executive’s employment with the Company (collectively, the “Claims”).
The Executive agrees to promptly inform the Company if the Executive becomes aware of any lawsuits involving Claims that may be filed or threatened against the Company or its affiliates. During the foregoing period, the Executive also agrees to
promptly inform the Company (to the extent that the Executive is legally permitted to do so) if the Executive is asked to assist in any investigation of the Company or its subsidiaries (or their actions) or another party attempts to obtain
information or documents from the Executive (other than in connection with any litigation or other proceeding in which the Executive is a party-in-opposition) with
respect to matters the Executive believes in good faith to relate to any investigation of the Company or its affiliates, in each case, regardless of whether a lawsuit or other proceeding has then been filed against the Company or its affiliates with
respect to such investigation, and shall not do so unless legally required. During the pendency of any 

  
 15 

 
litigation or other proceeding involving Claims, the Executive shall not communicate with anyone (other than the Executive’s attorneys and tax and/or financial advisors and except to the
extent that the Executive determines in good faith is necessary in connection with the performance of the Executive’s duties hereunder) with respect to the facts or subject matter of any pending or potential litigation or regulatory or
administrative proceeding involving the Company or any of its affiliates without giving prior written notice to the Company or the Company’s counsel. Upon presentation of appropriate documentation, the Company shall pay or reimburse the
Executive for all reasonable out-of-pocket travel, duplicating or telephonic expenses incurred by the Executive in complying with this
Section 10. It is expressly agreed that the Company’s rights to avail itself of the Executive’s advice and consultation services shall at all times be exercised in a reasonable manner, and that adequate notice
shall be given to the Executive in such events. 
 11. Notice. For purposes of this Agreement, notices and all other communications
provided for in this Agreement shall be in writing and shall be deemed to have been duly given (a) on the date of delivery, if delivered by hand, (b) on the date of transmission, if delivered by confirmed facsimile or electronic mail,
(c) on the first business day following the date of deposit, if delivered by guaranteed overnight delivery service, or (d) on the fourth business day following the date delivered or mailed by United States registered or certified mail,
return receipt requested, postage prepaid, addressed as follows: 
 If to the Executive: 

At the address (or to the facsimile number) shown 

in the books and records of the Company. 

With copies to (which shall not constitute notice): 

McDonald Hopkins LLC 
 300 N.
LaSalle St., Suite 1400 
 Chicago, IL 60654 

Email:          [***] 

Attention:     Benjamin Panter 

If to the Company: 

Alight Solutions LLC 
 4
Overlook Point 
 Lincolnshire, IL 60069 

Email: [***] 
 Attention:
    Paulette Dodson, General Counsel 
 Following the date hereof, notice may be delivered to either party at such other address as
either party hereto may hereafter designate in writing to the other. Any such notice shall be deemed effective upon receipt thereof by the addressee. 

12. Section Headings; Inconsistency. The section headings used in this Agreement are included solely for convenience and shall not
affect, or be used in connection with, the interpretation of this Agreement. In the event of any inconsistency between the terms of this Agreement and any form, award, plan or policy of the Company, the terms of this Agreement shall govern and
control. 

  
 16 

 13. Severability. The provisions of this Agreement shall be deemed severable. The
invalidity or unenforceability of any provision of this Agreement in any jurisdiction shall not affect the validity, legality or enforceability of the remainder of this Agreement in such jurisdiction or the validity, legality or enforceability of
any provision of this Agreement in any other jurisdiction, it being intended that all rights and obligations of the parties hereunder shall be enforceable to the fullest extent permitted by applicable law. 

14. Counterparts. This Agreement may be executed in several counterparts, each of which shall be deemed to be an original but all of
which together will constitute one and the same instrument. 
 15. Withholding. The Company may withhold from all payments due to the
Executive under this letter agreement all taxes which, by applicable federal, state, local, or other law, the Company is required to withhold therefrom. 

16. Section 409A. 

(a) The intent of the parties is that payments and benefits under this Agreement comply with or be exempt from
Section 409A and, accordingly, to the maximum extent permitted this Agreement shall be interpreted to be in compliance therewith or exempt therefrom. Neither the Company nor any of its affiliates shall be liable for any additional tax, interest
or penalty that may be imposed on the Executive by Section 409A or damages for failing to comply with Section 409A. 

(b) All expenses or other reimbursements under this Agreement that would constitute nonqualified deferred compensation subject
to Section 409A, (i) shall be paid on or prior to the last day of the taxable year following the taxable year in which such expenses were incurred by the Executive, (ii) no such reimbursement or expenses eligible for reimbursement in
any taxable year shall in any way affect the Executive’s right to reimbursement of any other expenses eligible for reimbursement in any other taxable year, and (iii) the Executive’s right to reimbursement shall not be subject to
liquidation in exchange for any other benefit. 
 (c) For purposes of Section 409A, the Executive’s right to
receive any installment payment pursuant to this Agreement shall be treated as a right to receive a series of separate and distinct payments. 

(d) Whenever a payment under this Agreement specifies a payment period with reference to a number of days (e.g., “payment
shall be made within thirty (30) days following the date of termination”), the actual date of payment within the specified period shall be within the sole discretion of the Company. 

  
 17 

 (e) Notwithstanding any other provision of this Agreement to the contrary,
in no event shall any payment under this Agreement that constitutes nonqualified deferred compensation subject to Section 409A, be subject to offset, counterclaim or recoupment by any other amount payable to the Executive unless otherwise
permitted by Section 409A. 
 17. Assignment. 

(a) This Agreement is personal to the Executive and, without the prior written consent of the Company, will not be assignable
by the Executive otherwise than by will or the laws of descent and distribution, and any assignment in violation of this Agreement will be void. Notwithstanding the foregoing sentence, this Agreement and all of the Executive’s rights hereunder
will inure to the benefit of and be enforceable by the Executive’s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees. 

(b) The Company will require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all
or substantially all of the business or assets of the Company (a “Successor”) to assume and agree to perform this Agreement in the same manner and to the same extent that the Company would have been required to perform it if no such
succession had taken place. As used in this Agreement, the term “Company” will mean the Company as defined herein and any Successor and any permitted assignee to which this Agreement is assigned. 

18. Amendment/Waiver. No provisions of this Agreement may be amended, modified, waived or discharged except by a written document signed
by the Executive and a duly authorized officer of the Company. The failure of a party to insist upon strict adherence to any term of this Agreement on any occasion will not be considered a waiver of such party’s rights or deprive such party of
the right thereafter to insist upon strict adherence to that term or any other term of this Agreement. 
 19. Entire Agreement. This
Agreement sets forth the entire agreement of the parties hereto in respect of the subject matter contained herein and supersedes all prior agreements. promises, covenants, arrangements, communications, representations or warranties, whether oral or
written, by any officer, employee or representative of any party hereto, including but not limited to the Term Sheet (other than with respect to the Incentive Unit Agreement and the Bonus Agreement). None of the parties will be liable or bound to
any other party in any manner by any representations and warranties or covenants relating to such subject matter except as specifically set forth herein. 

20. Governing Law; Venue. The validity, interpretation, construction and performance of this Agreement will be governed by the laws of
the State of Delaware, without giving effect to its conflicts of law. Each party hereto (i) irrevocably agrees that any legal action, suit or proceeding against it arising out of or in connection with this Agreement shall be brought exclusively
in the Court of Chancery of the State of Delaware (unless the federal courts have exclusive jurisdiction, in which case each party consents to the jurisdiction of the United States District Court for the District of Delaware), (ii) unconditionally
waives any objection to venue in such jurisdiction, and agrees not to plead or claim forum non conveniens, and (iii) waives their respective rights to a jury trial of any and such legal action, suit or proceeding. 

  
 18 

 21. Representations. The Executive represents and warrants to the Company that
(a) the Executive has the legal right to enter into this Agreement and to perform all of the obligations on the Executive’s part to be performed hereunder in accordance with its terms, and (b) the Executive is not a party to any
agreement or understanding, written or oral, and is not subject to any restriction, which, in either case, could prevent the Executive from entering into this Agreement or performing all of the Executive’s duties and obligations hereunder. 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 

  
 19 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date
first written above. 
  

					
	ALIGHT SOLUTIONS LLC	 		 	
			
	By: /s/
Paulette Dodson                                      
                        	 		 	August 18, 2021
	Name: Paulette Dodson	 		 	  
 Date

	Title: General Counsel and Corporate Secretary	 		 	
			
	EXECUTIVE	 		 	
			
	/s/ Stephan Scholl	 		 	August 16, 2021
	  
 Stephan Scholl
	 		 	  
 Date

 EXHIBIT A 

GENERAL RELEASE 
 I,
                , in consideration of and subject to the performance by [Alight Solutions Inc.] (together with its subsidiaries and affiliates, the
“Company”), of its obligations under the Employment Agreement dated as of [•], 2021 (the “Agreement”), do hereby release and forever discharge as of the date hereof the Company and its respective affiliates and
all present, former and future managers, directors, officers, employees, successors and assigns of the Company and its affiliates and direct or indirect owners (collectively, the “Released Parties”) to the extent provided below
(this “General Release”). The Released Parties are intended to be third-party beneficiaries of this General Release, and this General Release may be enforced by each of them in accordance with the terms hereof in respect of the
rights granted to such Released Parties hereunder. Terms used herein but not otherwise defined shall have the meanings given to them in the Agreement. 

1. My employment or service with the Company and its affiliates terminated as of [________], and I hereby resign from any position as an
officer, member of the board of managers or directors (as applicable) or fiduciary of the Company or its affiliates (or reaffirm any such resignation that may have already occurred). I understand that any payments or benefits paid or granted to me
under Section 8(d) of the Agreement represent, in part, consideration for signing this General Release and are not salary, wages or benefits to which I was already entitled. I understand and agree that I will not receive
certain of the payments and benefits specified in Section 8(d) of the Agreement unless I execute this General Release and do not revoke this General Release within the time period permitted hereafter. I understand and agree
that such payments and benefits are subject to Sections 8, 9, and 10 of the Agreement, which (as noted below) expressly survive my termination of employment and the execution of this General Release. Such payments and benefits
will not be considered compensation for purposes of any employee benefit plan, program, policy or arrangement maintained or hereafter established by the Company or its affiliates. 

2. Except as provided in paragraphs 4 and 5 below and except for the provisions of the Agreement which expressly survive the termination of my
employment with the Company, I knowingly and voluntarily (for myself, my heirs, executors, administrators and assigns) release and forever discharge the Company and the other Released Parties from any and all claims, suits, controversies, actions,
causes of action, cross-claims, counter claims, demands, debts, compensatory damages, liquidated damages, punitive or exemplary damages, other damages, claims for costs and attorneys’ fees, or liabilities of any nature whatsoever in law and in
equity, both past and present (through the date that this General Release becomes effective and enforceable) and whether known or unknown, suspected, or claimed against the Company or any of the Released Parties which I, my spouse, or any of my
heirs, executors, administrators or assigns, may have, (i) from the beginning of time through the date upon which I execute this Agreement; (ii) arising out of, or relating to, my employment with any Released Parties; (iii) arising
out of, or relating to, any agreement and/or any awards, policies, plans, programs or practices of the Released Parties that may apply to me or in which I may participate, including, but not limited to, any rights under bonus plans or programs of
Released Parties and/or any other short-term or long-term equity-based or cash-based incentive plans or programs of the Released Parties; 

  
 A-1 

 
or (iv) arising out of or connected with my employment with, or my separation or termination from, the Company, including, but not limited to, any allegation, claim or violation, arising
under Title VII of the Civil Rights Act of 1964, as amended; the Civil Rights Act of 1991; the Age Discrimination in Employment Act of 1967, as amended (including the Older Workers Benefit Protection Act); the Equal Pay Act of 1963, as amended; the
Americans with Disabilities Act of 1990; the Family and Medical Leave Act of 1993; the Worker Adjustment Retraining and Notification Act; the Employee Retirement Income Security Act of 1974; any applicable Executive Order Programs; the Fair Labor
Standards Act; or their state or local counterparts; or under any other federal, state or local civil or human rights law, or under any other local, state, or federal law, regulation or ordinance; or under any public policy, contract or tort, or
under common law; or arising under any policies, practices or procedures of the Company; or any claim for wrongful discharge, breach of contract, infliction of emotional distress, defamation; or any claim for costs, fees, or other expenses,
including attorneys’ fees incurred in these matters) (all of the foregoing collectively referred to herein as the “Claims”). 

3. I represent that I have made no assignment or transfer of any right, claim, demand, cause of action, or other matter covered by paragraph 2
above. 
 4. I agree that this General Release does not waive or release any rights or claims that I may have under the Age Discrimination in
Employment Act of 1967 which arise after the date I execute this General Release. I acknowledge and agree that my separation from employment with the Company in compliance with the terms of the Agreement shall not serve as the basis for any claim or
action (including, without limitation, any claim under the Age Discrimination in Employment Act of 1967). 
 5. I agree that I hereby waive
all rights to sue or obtain equitable, remedial or punitive relief from any or all Released Parties of any kind whatsoever in respect of any Claim, including, without limitation, reinstatement, back pay, front pay, and any form of injunctive relief.
Notwithstanding the above, I further acknowledge that I am not waiving and am not being required to waive any right that cannot be waived under law, including the right to file an administrative charge or participate in an administrative
investigation or proceeding; provided, however, that I disclaim and waive any right to share or participate in any monetary award resulting from the prosecution of such charge or investigation or proceeding. Additionally, I am not
waiving (i) any right to the Accrued Amounts or any severance benefits to which I am entitled under the Agreement, (ii) any claim relating to directors’ and officers’ liability insurance coverage or any right of indemnification
under the Company’s organizational documents or otherwise, or (iii) my rights as an equity or security holder in the Company or its affiliates. 

6. In signing this General Release, I acknowledge and intend that it shall be effective as a bar to each and every one of the Claims
hereinabove mentioned or implied. I expressly consent that this General Release shall be given full force and effect according to each and all of its express terms and provisions, including those relating to unknown and unsuspected Claims
(notwithstanding any state or local statute that expressly limits the effectiveness of a general release of unknown, unsuspected and unanticipated Claims), if any, as well as those relating to any other Claims hereinabove mentioned or implied. I
acknowledge and agree that this waiver is an essential and material term of this General Release and that without such waiver the Company would not have agreed to the terms of the Agreement. I further agree that in the event I should

  
 A-2 

 
bring a Claim seeking damages against the Company, or in the event I should seek to recover against the Company in any Claim brought by a governmental agency on my behalf, this General Release
shall serve as a complete defense to such Claims to the maximum extent permitted by law. I further agree that I am not aware of any pending claim of the type described in paragraph 2 above as of the execution of this General Release. 

7. I agree that neither this General Release, nor the furnishing of the consideration for this General Release, shall be deemed or construed at
any time to be an admission by the Company, any Released Party or myself of any improper or unlawful conduct. 
 8. I agree that if I violate
this General Release by suing the Company or the other Released Parties I will pay all costs and expenses of defending against the suit incurred by the Released Parties, including reasonable attorneys’ fees. 

9. I agree that this General Release and the Agreement are confidential and agree not to disclose any information regarding the terms of this
General Release or the Agreement, except to my immediate family and any tax, legal or other counsel I have consulted regarding the meaning or effect hereof or as required by law, and I will instruct each of the foregoing not to disclose the same to
anyone. 
 10. Any non-disclosure provision in this General Release does not prohibit or restrict me
(or my attorney) from responding to any inquiry about this General Release or its underlying facts and circumstances by the Securities and Exchange Commission (SEC), the Financial Industry Regulatory Authority (FINRA), any other self-regulatory
organization or any governmental entity. 
 11. I hereby acknowledge that Sections 8(d) and (e), 9, 10, and
13 through 21 shall survive my execution of this General Release. 
 12. I represent that I am not aware of any claim by me
other than the claims that are released by this General Release. I acknowledge that I may hereafter discover claims or facts in addition to or different than those which I now know or believe to exist with respect to the subject matter of the
release set forth in paragraph 2 above and which, if known or suspected at the time of entering into this General Release, may have materially affected this General Release and my decision to enter into it. 

13. Notwithstanding anything in this General Release to the contrary, this General Release shall not relinquish, diminish, or in any way affect
any rights or claims arising out of any breach by the Company or by any Released Party of the Agreement after the date hereof. 
 14.
Whenever possible, each provision of this General Release shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this General Release is held to be invalid, illegal or unenforceable in any
respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability shall not affect any other provision or any other jurisdiction, but this General Release shall be reformed, construed and enforced in such
jurisdiction as if such invalid, illegal or unenforceable provision had never been contained herein. 

  
 A-3 

 BY SIGNING THIS GENERAL RELEASE, I REPRESENT AND AGREE THAT: 

1. I HAVE READ IT CAREFULLY; 
 2.
I UNDERSTAND ALL OF ITS TERMS AND KNOW THAT I AM GIVING UP IMPORTANT RIGHTS, INCLUDING BUT NOT LIMITED TO, RIGHTS UNDER THE AGE DISCRIMINATION IN EMPLOYMENT ACT OF 1967, AS AMENDED, TITLE VII OF THE CIVIL RIGHTS ACT OF 1964, AS AMENDED; THE EQUAL
PAY ACT OF 1963, THE AMERICANS WITH DISABILITIES ACT OF 1990; AND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974, AS AMENDED; 
 3. I
VOLUNTARILY CONSENT TO EVERYTHING IN IT; 
 4. I HAVE BEEN ADVISED TO CONSULT WITH AN ATTORNEY BEFORE EXECUTING IT AND I HAVE DONE SO OR,
AFTER CAREFUL READING AND CONSIDERATION, I HAVE CHOSEN NOT TO DO SO OF MY OWN VOLITION; 
 5. I HAVE HAD AT LEAST [21][45] DAYS FROM
THE DATE OF MY RECEIPT OF THIS RELEASE TO CONSIDER IT, AND THE CHANGES MADE SINCE MY RECEIPT OF THIS RELEASE ARE NOT MATERIAL OR WERE MADE AT MY REQUEST AND WILL NOT RESTART THE REQUIRED [21][45]-DAY PERIOD; 

6. I UNDERSTAND THAT I HAVE SEVEN (7) DAYS AFTER THE EXECUTION OF THIS RELEASE TO REVOKE IT AND THAT THIS RELEASE SHALL NOT BECOME
EFFECTIVE OR ENFORCEABLE UNTIL THE REVOCATION PERIOD HAS EXPIRED; 
 7. I HAVE SIGNED THIS GENERAL RELEASE KNOWINGLY AND VOLUNTARILY AND WITH
THE ADVICE OF ANY COUNSEL RETAINED TO ADVISE ME WITH RESPECT TO IT; AND 
 8. I AGREE THAT THE PROVISIONS OF THIS GENERAL RELEASE MAY NOT BE
AMENDED, WAIVED, CHANGED OR MODIFIED EXCEPT BY AN INSTRUMENT IN WRITING SIGNED BY AN AUTHORIZED REPRESENTATIVE OF THE COMPANY AND BY ME. 
  

					
	SIGNED:                                     
                                        
                           	 		 	DATED:                                     
                                         
                           

  
 A-4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}]]